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ABSTRACT

Lehman, Jason Alexander Ph.D., Biomedical Sciences Ph.D. Program, Wright State
University, 2008. Novel Redox and DNA-Dependent Conformational Changes in
Human Ku, a DNA-Double Strand Break Repair Protein
Ionizing radiation (IR) and radiomimetic drugs used in cancer chemotherapy
cause DNA double-strand breaks which are repaired by the nonhomologous end
joining (NHEJ) pathway. Ku is a heterodimeric protein comprised of 70 and 80 kDa
subunits and recognizes free DNA ends. Once Ku is bound to DNA, it binds to the
DNA-dependent protein kinase catalytic subunit (DNA-PKcs), and forms a
heterotrimeric DNA-PK complex for repair and damage signaling.
We have analyzed the Ku protein using multiple biochemical techniques and
uncovered a novel reversible redox change (Andrews, Lehman and Turchi, (2006)
JBC 281(19):13596-603). From this data, we hypothesized that a redox-dependent
conformational change was responsible for the unexplained differences in our DNA
binding assays. This was confirmed by limited proteolysis and mass spectrometry
analysis of oxidized and reduced Ku. The conformational change was manifested
by alterations in the Ku70 subunit in proximity to the DNA binding site. Our results
suggest a model for a Ku-DNA interaction that is altered by redox status upon DNA
damage in the cell.
In order to understand the complex structure of DNA-PK, we have initially
examined Ku-DNA interactions using advanced biochemical techniques. Structural
iv

studies on Ku by other groups have utilized truncated versions missing disordered
C-terminal domains (CTDs) from both subunits. Chemical modification with NHSbiotin and mass spectrometry were used to identify biotinylated reactive lysines.
Biotinylation of free Ku revealed several lysines on Ku which were reduced or
eliminated upon DNA binding. Interestingly, in the predicted C-terminal SAP domain
of Ku70, biotinylation patterns suggest a structural change at this site induced by
DNA binding. Limited proteolytic digests of free and DNA-bound Ku revealed a
series of unique peptides correlating to a change in the accessibility of the Ku70 and
Ku80 CTDs.

A 10 kDa peptide was also identified which was preferentially

generated under non-DNA-bound conditions and mapped to the Ku70 CTD. These
results indicate a DNA-dependent movement or structural change in the CTDs of
Ku70 and Ku80 that may contribute to DNA-PKcs binding and activation. This is the
first demonstration of DNA-dependent conformational changes in Ku and will aid in
discerning the mechanism of DNA-PK activation.
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I. BACKGROUND AND SIGNIFICANCE
DNA-double strand breaks and signaling:
DNA-double strand breaks (DSBs) are caused by a variety of exogenous
sources including ionizing radiation (IR) and radiomimetic drugs which are used for
treatment of cancer. In addition, endogenous sources such as reactive oxygen
species (ROS) generated during cellular metabolism, replication fork collapses, and
nuclease activity also can promote DSB formation. IR evokes a DNA-damage
checkpoint response that involves two main pathways: Non-homologous end joining
(NHEJ) and homologous recombination (HR). IR-induced DSBs signal to the ataxiatelangiectasia mutated protein (ATM) and causes downstream signaling to NHEJ
factors or the signal can be secondarily shunted to the HR pathway for repair of this
type of lesion. IR can also cause single-strand breaks (SSBs) and DNA base sugar
damage which causes stalling of replication forks signaling to the ataxiatelangiectasia and Rad3-related protein (ATR) for HR for direct repair and also the
base excision repair (BER) pathway to repair damaged bases (Jeggo and Lobrich,
2006). Thus, IR activates multiple pathways to facilitate repair of a wide type of DNA
damage, yet primarily causes DSBs inducing NHEJ.
Homologous recombination:
The use of homologous recombination with a chromosome as a DNA
template is infrequently used in the cell except in certain instances. HR involves
the use of a sister chromatid as a template for repair of the DSB and occurs only
1

in S or G2 phase in mammals (Jeggo and Lobrich, 2006). Primary steps in HR
involve generation of single-stranded DNA to which replication protein A binds
followed by template DNA invasion by the Rad51 protein. Other steps involved
are formation of a Holliday junction structure, branch migration and resolution. A
cadre of proteins are used in this pathway including BRCA1, BRCA2, Rad54 and
others.
Human non-homologous end joining:
Non-homologous end joining (NHEJ) mediated DNA double-strand break
(DSB) repair can occur at all phases of the cell cycle and is the primary way to
resolve DSBs within mammalian cells. NHEJ involves the recognition, binding
and repair of breaks in DNA that possess either blunt-ended, sticky, 5´ or 3´
overhangs. Repair can include regions with or without microhomology of a few
base pairs in DNA sequence. The initial steps of the recognition of broken DNA
ends from damage involve a complex set of protein-protein, protein-nucleic acid
interactions and phosphoprotein signaling that is just beginning to be elucidated.
DNA ends must be processed by either deletion or addition of nucleotides when
necessary, which is a very active area of current NHEJ studies. By definition,
one DNA end containing a 5´ phosphate and the other DNA end with a 3´
hydroxyl must be linked together by ligation to finalize DNA repair. The most
resilient feature of this process is that any DNA coding for gene sequences must
be preserved without deletion within exon sequences. Without this repair
process, breaks in DNA can lead to polymerase errors or stalling/collapse of
replication forks. The enzymatic steps of NHEJ and primary proteins involved in
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double-strand break repair are reviewed in (Lees-Miller and Meek, 2003; Hefferin
and Tomkinson, 2005; Lieber, 2008; Lieber et al., 2008).
A partial reconstitution of NHEJ has been performed using a plasmid
rejoining assay with cellular extracts and in vitro assays with some of the purified
core proteins. However, new factors are still being discovered and individual
biochemical steps of NHEJ carried out by the core proteins are still being
elucidated. Human lymphoblastoid cell-lines were used to make extracts that
could catalyze the joining of two DNA ends with 5´, 3´ or blunt ends from
linearized plasmids. End-joining was found to require DNA ligase IV, XRCC4,
Ku70, Ku80 and the DNA-dependent protein kinase catalytic subunit (DNA-PKcs)
for in vitro repair of DNA (Baumann and West, 1998). This seminal paper in the
field laid the groundwork for the use of purified proteins to measure NHEJ
activity. However, this assay represents only some of the versions of DSBs that
a cell might experience. Other assays have taken into account more
physiological conditions represented by DNA double strand breaks based on free
radical damage (Chen et al., 2001). A schematic for the non-homologous endjoining repair pathway is shown in Figure 1.
NHEJ proteins:
Proteins involved in the recognition step of NHEJ include Ku70, Ku80 and
DNA-PKcs. Ku70 and Ku80 are typically found as a heterodimer for doublestrand break repair which is mediated by protein-protein interactions between the
two subunits (Cary et al., 1998). This interaction is also necessary for the
response to ionizing radiation and DSB repair as demonstrated by addition of the
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Ku70 subunit back to cells null for that subunit (Jin and Weaver, 1997). The Ku
heterodimer is known to arrive first at sites of DSBs. Ku increases the affinity of
DNA-PKcs for the DNA ends with protein-protein interactions involved between
the heterotrimeric DNA-PK complex (Gottlieb and Jackson, 1993). Ku and DNAPKcs are estimated to be present at around 400,000 molecules of Ku and
200,000 of DNA-PKcs in the HeLa nuclear cell (P. Douglas et al., 2002). Ku and
DNA-PKcs are already in the right proximity to the DNA ends likely due to their
high abundance in nuclear extracts explains their mechanism of loading onto
break sites. Biochemically, both Ku and DNA-PKcs have a strong affinity for the
3’- and 5’-recessed and blunt-ended DNA they bind to initiate the repair process
(Mimori and Hardin, 1986; Zhang and Yaneva, 1992; Blier et al., 1993; West et
al., 1998). The importance of both Ku and DNA-PKcs in DNA repair has been
demonstrated in a series of knockout mice and cell lines absent of these
proteins. In humans and other mammalian cells a defect of DNA-dependent
protein kinase leads to a defect known as severe combined immunodeficiency
(SCID) caused by ineffective Variable (V) Diversity (D) and Joining (J)
recombination.
V(D)J recombination is the process that involves the breaking and joining
of DNA induced by the recombinase activation genes (RAG1/2) for generation of
antibody diversity, which is reviewed in (Soulas-Sprauel, 2007; Weterings and
Chen, 2008). Cells derived from scid mice are defective in V(D)J recombination
and NHEJ, and have been shown to be absent of the DNA-dependent protein
kinase catalytic subunit (Peterson et al., 1995). The M059J (DNA-PKcs null) and
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M059K (+ for DNA-PKcs) glioma cell lines have been derived and a defect in the
PKRDC gene which encodes for DNA-PKcs shows defects in NHEJ and
radiation hypersensitivity (Anderson et al., 2001). Ku70-deficiency in mice leads
to an impairment of V(D)J recombination, radiation sensitivity in fibroblasts, and
an absence of B-cells (Gu et al., 1997). A similar phenotype is observed in Ku80
knockout mice and embryonic stem cells derived from a knockout model.
Studies in human cells underscore the importance of the Ku80 subunit. When
the Ku80 gene is deleted in the background of a p53 null phenotype in a human
cell line, cells are still not viable (Ghosh et al., 2007). Cells that overexpress
some DNA repair proteins that have been deleted can be rescued from lethality
by concurrently knocking out p53. Thus, Ku and DNA-PKcs represent very
essential genes for efficient antibody diversity and protection from IR-induced
DNA damage.
DNA ligase IV is the enzyme that catalyzes the specific ligation event for
non-homologous end joining and can not be substituted by another DNA ligase
activity. This has been demonstrated by substitution of other mammalian DNA
ligases into cells with a targeted disruption of the DNA ligase IV gene, where only
addition of DNA ligase IV could rescue radiation sensitivity and V(D)J
recombination defects (Grawunder et al., 1998). It forms a heterodimer for this
process with the XRCC4 gene product through its carboxy terminus and is
termed the L4/X4 complex. A crystal structure of the DNA ligase IV complexed
with XRCC4 on DNA has revealed that two domains of XRCC4 bind to a single
peptide of ligase IV and undergo unwinding to form a very stable protein-protein
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interaction (Sibanda et al., 2001). A knockout of DNA ligase IV has revealed that
it is essential in developmental processes as it leads to embryonic lethality with
severe apoptosis in the central nervous system (Barnes et al., 1998). Cells
without XRCC4 are defective in V(D)J recombination and are hypersensitive to
ionizing radiation (Li et al., 1995). Ku also promotes efficient DNA ligation by
stimulating the activity of the LIV/X4 complex (Nick McElhinny et al., 2000)
These results demonstrate that when essential NHEJ proteins are deleted from
cells they show inefficient DSB repair, defects in V(D)J recombination and
hypersensitivity to radiation.
To facilitate nucleotide addition and deletion, nucleases and polymerases
contribute to the NHEJ pathway. If this were not the case, then there would be a
higher incidence of mutation and loss of gene products. Artemis is a recently
discovered enzyme that is essential for the NHEJ pathway and V(D)J
recombination. Artemis was found to form a protein interaction with DNA-PKcs
and is phosphorylated by that enzyme. The Artemis enzyme alone has 5´ to 3´
exonuclease activity, and when activated by DNA-PKcs has an endonuclease
activity on hairpins, 5´ and 3´ overhangs is stimulated (Ma et al., 2002). An
Artemis deficiency in murine embryonic stem cells leads to slight radiation
sensitivity and large problems with DNA end processing in both NHEJ and V(D)J
recombination leading to severe genomic instability (Rooney et al., 2003). The
Artemis nuclease has been shown to be phosphorylated by DNA-PKcs in vitro at
11 sites in its C-terminal domain and 3 novel DNA-PKcs autophosphorylation
sites, Ser3821, Ser4026 and Thr4102, were also discovered (Ma et al., 2005).
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Artemis endonuclease activity to cleave a variety of substrates is also dependent
on DNA-PK phosphorylation (Goodzari et al., 2006). Phosphorylation of the Cterminus of Artemis by DNA-PKcs results in a conformational change that results
in relief of autoinhibition of Artemis and subsequent activation of the
endonucleolytic activity (Niewolik et al., 2006). Therefore, the biological activity
of the Artemis enzyme to resolve DNA ends and structures appears to be
regulated by phosphorylation by the DNA-dependent protein kinase.
Another nuclease complex known as MRN (Mre11/RAD50/NBS1) has
been reported to have an effect on processing of DNA in DSB repair. MRN
possesses a weak endonuclease activity, but primarily carries out 3′ to 5′
exonuclease activity on blunt and 3′ recessed ends through the Mre11 subunit.
MRN was identified and complemented extracts from several steps of purification
in an end-joining repair assay back to the crude extract level of NHEJ repair
(Huang and Dynan, 2002). Recent data suggest that this protein may not be
essential for the process of human NHEJ, but is likely important for double-strand
break repair in yeast. Depletion of Mre11 was shown not to have an effect on
NHEJ in a Xenopus cell-free system (Di Virgilio and Gautier, 2005).
The X-family of DNA polymerases appear that they might be necessary for
human non-homologous end joining. Some members of this class of
polymerases, pol µ and pol λ, appear that they might serve this purpose. Pol µ
levels were found to increase in cells upon IR exposure and be associated in a
complex with Ku and L4/X4 stimulating end joining in extracts (Mahajan et al.,
2002). Both pol µ and pol λ were shown to participate in end joining reactions
7

dependent on the presence of Ku and L4/X4 to elicit gap-filling on a large
substrate with partially complementary 3´ overhangs (Nick McElhinny et al.,
2005). A solution structure of the BRCT domain in pol µ has revealed a unique
arrangement for protein-protein interactions in this region. Mutation of three
conserved amino acids or deletion of the BRCT domain led to a decrease in Kustimulated LIV/X4 ligation in an in vitro rejoining assay (DeRose et al., 2007).
Furthermore, the BRCT domain of pol µ has high sequence homology throughout
evolution to terminal deoxynucleotidyltransferase (Tdt), in particular, the
aforementioned amino acids that were mutated suggesting this polymerase also
functions in NHEJ. Thus, the inclusion of DNA polymerases that can add the
correct nucleotide after a DSB has occurred represents a logical and
understudied area of NHEJ research.
A radiosensitive and double-strand break deficient cell line derived from a
patient, 2BN, was found to still suffer non-homologous end joining deficiencies
even after complementation from all essential NHEJ factors (Dai et al., 2003).
This led to the hypothesis that another essential factor was thought to be missing
from the non-homologous end joining and V(D)J recombination pathway.
Indeed, a few years later a novel 33 kDa NHEJ factor called Cernunnos-XLF,
that forms interactions with DNA ligase IV and XRCC4 and its downregulation
leads to NHEJ impairment was discovered by two groups (Ahnesorg et al., 2006;
Buck et al., 2006). Both groups found that it was required for in vivo and in vitro
NHEJ of DNA substrates and complemented DNA repair defects. Ku has been
recently shown to recruit XLF to sites of DSBs by live cell imaging, and
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biochemical data suggests that a direct interaction between the two proteins
occurs (Yano et al., 2008). A partial crystal structure of amino acids 1-233 of an
XLF homodimer reveals that it has an unusual coiled-coil domain and represents
a unique structure than the XRCC4 protein (Li et al., 2008). Also, this study
determined that XLF is likely found as a homodimer versus a an XLF-XRCC4
heterodimer as previously was suggested from other studies.
NHEJ cofactors:
Aside from the obvious requirement of broken ends as a cofactor for nonhomologous end joining, the only other known component for this pathway is
inositol hexakisphosphate (IP6). In search of an unknown protein cofactor that
stimulated in vitro NHEJ the S.C. West group purified IP6 and found that it
specifically stimulated DNA-PK dependent end joining (L. Hanaki et al., 2000).
Surprisingly, the same group later found that IP6 interacted specifically with Ku
and not DNA-PKcs, and appears to be specific for mammalian systems
(Hanakahi and West, 2002). This work generated more unanswered questions,
such as, does in vivo NHEJ actually require IP6 as a stimulatory factor and
structurally where does IP6 bind on Ku? Limited proteolysis work generated by
our laboratory where the pH was adjusted in the samples prior to digestion with
trypsin revealed no difference between IP6-bound and free Ku (data not shown).
Ku-DNA binding:
Ku is a unique DNA-binding protein because it utilizes its 3-dimensional
structure to bind duplex DNA ends and translocates inward on DNA. Ku
accomplishes DNA binding through sugar-phosphate interactions from
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hydrophobic and positively charge amino acids. Therefore, Ku’s ability to bind
DNA is independent of the sequence of DNA. This is supported by numerous
studies where Ku bound to duplex DNA substrates without specificity to DNA
sequences (Zhang and Yaneva, 1992; Blier et al., 1993; West et al., 1998).
However, there have been controversial reports that Ku will bind single-stranded
DNA and specific DNA sequences. Ku has been reported to bind to a negative
regulatory element (NRE1) DNA sequence of the mouse mammary tumor virus,
MMTV (Giffin et al., 1996). The authors demonstrated that Ku binding to this
specific sequence represses viral transcription of MMTV. This same group also
found that Ku bound the upper single-strand DNA NRE1 element (Torrance et
al., 1998). Crosslinking of Ku subunits was observed, such that Ku80
crosslinked only to ss-NRE1, while Ku70 crosslinked to both ss- and ds-DNA
containing the NRE1 element. Therefore, it is accepted that Ku prefers duplex
DNA with blunt ends, partial overhangs regardless of specific DNA base
composition and will bind ss-DNA with less affinity.
It is very important to discuss the unique structure of Ku when talking
about DNA binding. The first structural analysis of Ku was done at low resolution
with small angle X-ray and neutron scattering and determined DNA
oligonucleotides of 24 bases in length to be completely covered by Ku, while an
oligo of 30 bases in length had partial protrusion of DNA. The structure of Ku
adopted an ellipsoid shape and to contain a unique preformed channel through
which DNA would thread (Zhao et al., 1999). Photocrosslinking Ku to DNA to
determine the directionality of how the subunits load onto to DNA and amino
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acids that might make contact to the backbone has been investigated (Yoo et al.,
1999). DNA substrates were designed to prevent Ku movement by blockage of
one end with a 5′ biotin when streptavidin was added to force the heterodimer to
load onto the DNA in a specific direction. Ku70 was determined to make contact
with the major groove at multiple sites closer to the free DNA end, while Ku80
made contact with the minor groove and was located closer to the blocked DNA
end. Ku loading rates have been observed on longer DNA substrates blocked at
one end with a biotin/streptavidin complex. It was determined that multiple Ku
molecules (up to 5) could load onto a long DNA substrate of greater than 100
nucleotides and the structural alteration in DNA induced by the DNA damaging
cisplatin slowed the rate of Ku loading (Turchi et al., 2000). Cisplatin-bound DNA
still allowed for multiple Ku molecules to bind the free DNA end and translocate
along inward. Ku movement was stopped by the blocked end which agreed with
the prediction of a preformed channel between Ku70 and Ku80. One study found
that 1 molecule of Ku would bind per 25 bp duplex DNA with no cooperativity
were seen between 2 or more Ku molecules on longer length substrates (Arosio
et al., 2002). The same group used fluorescence anisotropy of Ku binding to
DNA to determine the contribution of ionic effects and electrostatic interactions.
When salt concentration was lowered from 300 mM a decrease in kd was
observed with cationic and anionic release from DNA and Ku (Arosio et al.,
2004). These studies demonstrate that even without sequence specificity, Ku
binding and translocating along duplex DNA is a dynamic process.
Ku70/80 heterodimer structure:
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The crystal structure for Ku was solved in 2001 and revealed that the
heterodimer forms a central cavity where DNA is positioned and threaded
(Walker et al., 2001). A depiction of the Ku heterodimer is shown in Figure 2.
Both the Ku70/Ku80 subunits contribute to the overall shape of the
heterodimer. The orientation of both Ku subunits was also found to be in
agreement with crosslinking studies performed by Dynan and colleagues
(Yoo et al., 1999).

The free and DNA-bound crystals of Ku share nearly

identical crystal structures based on alignment of both backbone structures,
yet are missing a fair portion of both subunits. The 2.5 Ǻ structure of Ku was
determined on a substrate which contained 14 base pairs of duplex DNA with
a G-rich stem and small hairpin at one end that forms a three-dimensional
dumbbell, thereby trapping a single Ku molecule and preventing it from
dissociating on the opposite end. This length of duplex DNA represents the
minimum length that Ku is able to occupy. The Ku-DNA co-crystal structure
reveals several atypical features about the structure and function of Ku’s
protein-nucleic acid interactions. Despite the fact that there is not strong
sequence conservation between the Ku70 and Ku80 subunits, they adopt a
similar protein fold predominantly in the bridge-pillar region. The regions
mediating dimerization and DNA binding between both Ku subunits has been
mapped to a central region within amino acids approximately 430-482 and 1115 on Ku70 (Wang et al., 1998). In this part of the structure, strongelectrostatic interactions fuse the two subunits together to form the channel
through which the DNA threads. The structural study also revealed that
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multiple positively charged and hydrophobic amino acids on Ku make contact
with sugars and phosphates on the DNA backbone rather than with the
bases (Walker et al., 2001). This supports previous biochemical data from
other labs that hypothesized that Ku binds in a sequence independent
manner. Both Ku70 and Ku80 residues make contact in both the major and
minor grooves of DNA. Both subunits of Ku also share a general domain
feature in three regions: an N-terminal α/β domain which is related to the von
Willebrand A (vWA) domain, a β-barrel domain and a helical C-terminal arm.
The vWA domain of the Ku70 subunit is orientated towards the end of the
DNA break, while the Ku80 vWA domain comes in contact with the dumbbellshaped end of the substrate used for crystallization.
Two very important regions are absent from the final DNA-bound structure
of Ku: the Ku80 C-terminal region (amino acids 565-732) and the Ku70 Cterminal SAP domain (amino acids 559-609). The Ku80 C-terminal domain
(CTD) depicted in Figure 3 is known to bind and interact with DNA-PKcs.
Interest in resolving its structure has led to two separate NMR studies being
performed (Harris et al., 2004; Zhang et al., 2004). Both studies resolved an
overall structure of Ku80 CTD which starts with a very flexible linker, forms six αhelices and ends in a loop. The Ku80 CTD contains a high number of conserved
amino acids through higher organisms that are comprised within its 6 α-helical
bundles (Harris et al., 2004). Both studies have compared the fold similarity that
the Ku80 CTD adopts to other protein domains. One study found structural
homology to the MIF4G domain of the human nuclear cap binding protein 80 kDa
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subunit and the VHS domain of HRS, a Drosophilia protein, although analysis
revealed no likely similar functionality (Harris et al., 2004). In addition to binding
DNA-PKcs, the Ku80 CTD has been hypothesized to serve a role for binding
other NHEJ protein partners. This is due to the helical hairpin repeats and
structural similarity to other proteins, such as the α-subunit of Rab
geranylgeranyltransferase that contains this same type of repeat and known to
interact in protein-protein interactions (Zhang et al., 2004). The importance of
both C-terminal domains on Ku has been investigated by purification and
resolving the individual domains. The C-terminal SAP (SAF-A/B, Acinus and
PIAS) domain of Ku70 shown in Figure 4 has been described as a conserved
DNA-binding domain with an NMR structure resolving this domain (Zhang et al.,
2001). The more N-terminal portion of this structure represents a flexible linker
(residues 536-560) which extends into a 3 α-helical structure in residues 561609. Deletion of parts of both regions demonstrated a loss of DNA-binding.
Therefore, both Ku CTDs appear to have unique individual 3-dimensional
structures which might be involved in DNA binding and forming unique proteinprotein interactions.
There has not been a completely detailed picture of how the entire
heterodimer assembles itself on duplex DNA and changes its molecular
structure. Our laboratory has recently made a significant advance in answering
this question by carrying out solution structural studies using limited proteolysis
of free and DNA-bound Ku followed by probing with site-specific antibodies to
various regions of the heterodimer (Lehman et al., 2008). Both antibodies
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against the Ku70 and Ku80 C-terminal domains were able to recognize specific
peptides cut only under non-DNA bound conditions and were interpreted as
conformational changes in those regions. We were able to identify specific lysine
residues in the Ku70 C-terminal domain region that were modified only in the
absence of DNA by using amino acid chemical modification coupled with mass
spectrometry. A small 10 kDa proteolytic fragment generated only under nonDNA bound conditions was isolated and identified by mass spectrometry to
comprise the C-terminal SAP domain of Ku70 (Lehman et al., 2008). Therefore,
we demonstrated biochemically that both C-terminal domains of Ku undergo a
DNA-dependent conformational change. Recently, one study demonstrated in
yeast Ku that the heterodimer uses opposing faces for different functions.
Mutagenesis in yeast coupled with modeling of the human Ku structure
determined that α-5 on the surface of Ku70 was responsible for NHEJ, while α-5
on Ku80 is responsible for telomeric silencing (Ribes-Zimora et al., 2007). Given
the fair amount of conservation of amino acids from yeast to human that were
mutated in the study, it will be interesting to see if this α-helical structure plays
the same opposing roles in humans. Thus, structural changes in both C-terminal
domains manifest in Ku upon binding of duplex DNA.
Conditions that occur in vivo might affect a change in the structure of Ku
have been recently explored. Recently, the affect of nucleosome-bound DNA
was examined in the context of Ku loading. Ku was able to bind nucleosomebound DNA substrates and thread the DNA through the bridge-pillar region
(Roberts and Ramsden, 2007). The mechanism of this action was believed to be
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due to a peeling of the DNA end away from the nucleosomal surface. Ku was
hypothesized to use its structural bridge region to pry apart the DNA end from the
histone octamer surface. Our lab recently described a conformational change in
Ku dependent on whether the protein was oxidized or reduced (Andrews et al.,
2006). Redox conditions were found to reversibly alter the dissociation of Ku
from DNA, such that under oxidized conditions Ku dissociated more rapidly from
DNA than under reduced conditions. Through limited proteolysis and mass
spectrometry, peptides generated only under reduced-conditions were mapped
to the Ku70 subunit in the bridge-pillar region. This conformational change in Ku
occurred in close proximity to a cysteine amino acid that could potentially
modulate the observed redox effect. In addition to the binding of duplex DNA,
other conditions in the cell may affect the conformational state of the Ku
heterodimer. How this process occurs in vivo with identification of redoxmodulating proteins would be of great interest to investigate.
DNA-PKcs structure:
The enormity of the 469 kDa DNA-PKcs, has only allowed for low
resolution data represented by a combination of cryo-electron microscopy and
modeling programs. DNA-PKcs has been described to have head, palm and arm
regions and is structurally very similar to the related phosphatidyl-3-OH kinaserelated kinase (PIKK) family member, ATM (Boskovic et al., 2003). From the
cryo-EM data DNA-PKcs forms a large central cavity between its head and arm,
with a smaller cavity in the head region where the PIKK domain appears to
reside. The N-terminus of the kinase is known to contain a long series of HEAT
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(huntingtin-elongation-A-subunit-TOR) repeats that are contained in the Nterminal part of the sequence, which form helical hairpin repeats. HEAT repeats
are thought to be responsible for the more cylindrical regions of DNA-PKcs seen
in the cryo-EM model surrounding the open channel. A different α-helical repeat,
PFT (protein farnesyl transferase), lies in the sequence proceeding the PIKK
catalytic domain and might be responsible for the structural region that forms the
two open channels on either side of DNA-PKcs (Brewerton et al., 2004). By
comparison of the PIKK model of the PI3Kγ crystal structure to DNA-PKcs and
use of antibody epitope mapping, the C-terminus of DNA-PKcs was found to
structurally contain the kinase domain. Also, two domains termed the FAT and
FATC are found on opposite sides of the PIKK domain and appear to undergo a
DNA-induced conformational change as these two regions move closer together
(Rivera-Calzada et al., 2005).
Elucidation of the structure of DNA-PKcs including the Ku heterodimer has
remained a daunting task. Modeling of the heterotrimeric complex with the
addition of Ku and duplex DNA induces structural changes in the FAT and FATC
domains of DNA-PKcs and causes formation of a synaptic complex which relies
on two opposing heterotrimeric DNA-PK complexes (Spagnolo et al., 2006).
The cryo-EM studies do provide some physical evidence that when a DNA
double-strand break occurs there may be some crosstalk between DNA-PK
molecules at the DNA break-site, which could support an interesting model for
kinase activation. The most recent study took advantage of the full-length Ku
heterodimer, which included the C-terminal domains of Ku70 and Ku80. The
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Ku70 C-terminal region, which contains the DNA-binding SAP domain, possibly
undergoes a conformational change upon DNA and DNA-PKcs binding (A.
Rivera-Calzada et al. EMBO Reports 2007). The Ku80 CTD undergoes some
type of DNA-induced movement upon DNA-PKcs binding and possibly DNA
binding. The change in the Ku80 CTD was to a lesser visible degree than the
Ku70 CTD, which is completely consistent with results generated in our lab.
These studies provide low resolution insight into the mechanism of DNA-PK
dependent binding and conformational changes. Very recently, a 7 Ǻ resolution
cryo-EM structure of DNA-PKcs was done and similar to other studies it revealed
the same crown, base and channel pieces with an overall dimension of 120 Ǻ in
width and 150 Ǻ in length (Shimazaki and Lieber, 2008; Williams et al., 2008). A
representation of the current DNA-PKcs model with individual domains is shown
in Figure 5. Furthermore, two distinct possible DNA binding sites were resolved
within the crown/brow interface, and the kinase domain was found to be best fit
within the base region. However, more detailed biochemical structural
information is still needed to understand how this unique kinase binds and is
activated by DNA.
DNA-PKcs activation and phosphorylation:
Autophosphorylation is a very important part of activation of the DNAdependent protein kinase, since it uses DNA as a coeffector. DNA-PKcs binds
duplex DNA which leads to autophosphorylation of the catalytic subunit. Ku
binds DNA-PKcs and allows for an increase in activation of the kinase levels,
which after a short time interval leads to kinase inactivation and is thought to

18

release DNA-PKcs from Ku. Autophosphorylation sites on DNA-PKcs have been
found by mass spectrometry and confirmed with phosphospecific antibodies at
Thr2609, Ser2612, Thr2620, Ser2624, Thr2638 and Thr2647 in vitro and Thr2609, Ser2612,
Thr2638, Thr2647 in vivo (Douglas et al., 2002). A general motif of SQ/TQ
phosphorylation sites has been proposed for DNA-PK, ATM and ATR proteins,
yet very frequently true in vivo sites do not follow these concensus sites. Thr2609
was also confirmed as an in vivo target dependent on Ku and required for
response to IR-induced damage (Chan et al., 2002). More recently Ser2056
outside of the cluster of the other amino acids was also shown to be IR-inducible
and phosphorylated to a higher degree in different phases of the cell cycle (Chen
et al., 2005). Another DNA-PKcs phosphorylation site, T3950, has been
demonstrated to be functionally important for V(D)J recombination when mutated
and is also phosphorylated in vivo upon DNA damage (Douglas et al., 2007).
These recent papers hint at how much there is still to learn about the regulation
of DNA-PK and its autophosphorylation. There are many reported substrates for
DNA-PK, both in vivo and in vitro, but the current ideology is that the only
physiologically relevant target in vivo is DNA-PKcs. Ku was previously shown to
be phosphorylated on four residues Ser6 (Ku70) and Ser577, Ser580 and Thr715
(Ku80) by DNA-PK in vitro (Chan et al., 1999). These sites have consequently
been found to be phosphorylated in the absence of DNA-PKcs in vivo by an
unknown kinase (P. Douglas et al., 2005). DNA-PK dependent phosphorylation
sites on Ku have yet to be discovered that have some type of consequence for
NHEJ. These studies reveal that there is still much to learn on the enzymatic
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function of auto- and transphosphorylation by DNA-PK. Thus far, it appears that
Ser2056, Thr2609, and Thr3950 represent the most biologically relevant in vivo
phosphorylation sites on DNA-PKcs important for end-joining and/or radiation
responses, while representative sites on Ku remain elusive.
Redox Effects on Ku and DNA-PK:
A typical effect of IR-induced DNA damage is the production of free radical
species and a local change in the cellular oxidation/reduction status of proteins,
likely ones in NHEJ. Ku has been recognized to contain sulfhydryl-containing
amino acids which were important for binding to DNA. Inhibition of Ku binding to
DNA by diamide (oxidizing agent) could be reversed by addition of DTT (reducing
agent) and was dependent on sulfhydryl groups (Zhang and Yaneva, 1993). A
mutation of the glucose-6-phosphate dehydrogenase gene was found to have
negative effects on DNA-binding of Ku, but reversibility was seen when DTT was
supplemented to extracts (I.S. Ayene et al., 2002). Pharmacological studies
have looked at the effect of drugs that induce oxidative stress followed by
antioxidant treatment. Chlorambucil is a drug used for cancer treatment that
induces double strand breaks through DNA crosslinking, thereby increasing
reactive oxygen species (ROS). DNA-PK activity has been found to be
increased in cells treated with chlorambucil and also kinase activity was reduced
by treatment with oxidative stress mediators (Bacsi et al., 2005). Kinase activity
was preserved seen with pretreatment of cells with antioxidant compounds
followed by chlorambucil-mediated ROS. Another anticancer drug salvicine,
which also causes double strand breaks and ROS, was found to cause
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impairment of DNA-PKcs protein levels and when cells were pretreated with an
antioxidant kinase activity was preserved (Lu et al., 2005). Therefore, there is a
direct link between the oxidation/reduction status of the cell and proteins involved
in the NHEJ pathway.
Our lab previously discovered that redox status affected Ku binding to
DNA in vitro. Pre-steady state kinetics used to measure Ku-DNA interactions
with changes in intrinsic protein fluorescence revealed that Ku had noticeable
differences in kinetic traces where the presence of the reducing agent
dithiothreitol (DTT) led to fluorescent quenching of tryptophan that fit to a single
exponential curve. Partially oxidized Ku fluorescent quenching data fit to a
double exponential, whereas, completely oxidized Ku was not able to cause any
fluorescent quenching (Andrews et al., 2006). Similar effects were seen with βmercaptoethanol, a reducing agent, and different lengths and DNA structures.
Pretreatment of Ku with diamide, which completely oxidizes disulfides, followed
by addition of DTT revealed a reversible redox effect by fluorescence anisotropy.
Interestingly, Ku could change its conformation dependent on the redox state,
and a specific redox-sensitive region was determined by two different types of
mass spectrometry. This data proved that Ku was capable of undergoing a
redox-dependent structural change and will be discussed in detail in the Results
section.
Chemical modification and mass spectrometry:
While crystal structures do provide highly detailed information they are
also laden with problems, such as in the case of Ku where the C-terminal Ku80
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region was not crystallized because it is a highly disordered and flexible portion
of the protein. The problem with studies that separate protein domains into
distinct portions is that we lose information that might be critical in understanding
how a protein interacts with its physiological substrate. Recent advances in
methodology have allowed for the combined use of amino acid chemical
modification and mass spectrometry to probe proteins and their substrates for
interactions based on solvent accessibility and conformational changes. Highly
purified proteins can be treated with various chemical modification reagents that
attach to amino acid R-groups. Amino acid modification can be used to probe for
functions like binding to substrate and as a measure of solvent accessibility
which signify conformational change. MALDI-TOF or (matrix-assisted laser
desorption time-of-flight mass spectrometry) and LC-Q ion trap (liquid
chromatography-quadrapole) are two commonly used types of mass
spectrometers used for the analysis of peptides and chemically modified amino
acid residues.
N-hydroxysuccinimidobiotin (NHS-biotin), which is a selective primary
amine reagent that targets lysine amino acids, has been used to study the
contacts made by HIV reverse transcriptase in a viral RNA:tRNA complex (
Kvaratskhelia et al., 2002). NHS-biotin will covalently attach a biotin molecule to
solvent accessible lysines so a peptide will increase its expected mass by 226.3
daltons. Biotinylated peptides will have the presence of missed tryptic cut sites
on lysine amino acids where lysine was biotinylated. Any multisubunit protein
can be modified, separated by SDS-PAGE and have in-gel tryptic digestion
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performed prior to analysis by mass spectrometry. The nucleotide excision
repair recognition protein, replication protein A (RPA), has been studied in this
context and data determined that protein contacts to DNA were in agreement
with the known crystal structure and also revealed additional protein contacts
when NHS-biotin was used (Shell et al., 2005). Other hydrophobic amino acids
like tryptophans and tyrosines and positively charge arginines can also be
modified (Carven and Stern, 2005). In summary the combined use of chemical
modification of amino acids in conjunction with mass spectrometry allows for finedetailed structural information in solution to be generated. Since Ku, and DNAPKcs, have positively charged and hydrophobic amino acids that make contact
with the sugar-phosphate backbone of DNA, they provide useful targets for
chemical modification to study their protein structure. A schematic for the
biotinylation of free and DNA-bound Ku is depicted in Figure 6.
Biomedical Significance of NHEJ in Cancer Chemotherapy:
Resolution of DNA-double strand breaks without error is essential for the
maintenance of genomic integrity within a cell. This is directly dependent on the
functionality of both the NHEJ and HR systems. It has been hypothesized that
incorrect joining from NHEJ or non-compliance with repair of double-strand
breaks can lead to genomic instability and likely leads to the formation of a
cancerous cell. Mice knockouts of NHEJ proteins show abnormalities with DSB
repair and this increases in some specific types of cancer. On the opposite end
of preserving genomic integrity is the goal of killing cancer cells with drugs that
target NHEJ. Two agents that induce DSBs used in cancer chemotherapy are
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etoposide (VP-16) and IR. Etoposide is a topoisomerase inhibitor that causes
replication fork collapse and consequently DSBs. IR operates by a different
mechanism and causes DSBs, SSBs and ROS which leads to DNA base
damage and alterations in sugars. Studies from our lab demonstrate that when
compared to DNA-PKcs positive cells, DNA-PKcs null cells experience more
cellular death due to a synergistic effect when treated with two DNA-damaging
agents, cisplatin and ionizing radiation (Boeckman et al., 2005). Cisplatin, a drug
used heavily in various types of cancer treatments, leads to greater cell killing by
forming covalent adducts with DNA, which if not repaired lead to cellular
apoptosis. When a DSB with a platinum adduct at the end is subjected to repair
it is not able to be rejoined in a plasmid based assay with cellular extracts, and
was found to be directly dependent on DNA-PK (Boeckman et al., 2005).
Therefore, DNA-PK and the NHEJ pathway are critically implicated in IR
and cisplatin combination therapy for cancer. Studies examining the individual
protein-protein and protein-nucleic acid interactions of Ku, DNA-PK and other
proteins in the NHEJ pathway can lead to design of drugs that enhance
disruption of their molecular actions. Finding an effective small molecule inhibitor
which can effectively target Ku or DNA-PK could lead to smaller doses of IR that
might need to be used in a chermotherapy regimen. In turn, this might lead to an
ablation of more severe side-effects from receiving radiation therapy for the
patient. Thus, understanding the in vitro biochemistry and protein structure of
NHEJ proteins is important for the future status of cancer chemotherapy.
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Figure 1. Model of human non-homologous end joining (NHEJ) DNA repair. a.
The DNA double strand break (DSB) repair pathway is initiated by ionizing
radiation (IR) induced DNA damage. b. The Ku protein binds the free DNA end
where the break site is located and translocates inward along the DNA molecule.
c. The 469 kDa DNA-dependent protein kinase catalytic subunit (DNA-PKcs)
binds Ku and forms a heterotrimeric complex, DNA-PK, which likely involving
conformational changes between both proteins. d. The presence of the effector
DNA activates DNA-PK as a serine-threonine kinase and autophosphorylates
multiple residues on itself and phosphorylates other proteins in the NHEJ
pathway in a poorly understood manner. e. At some point by an unknown
mechanism DNA-PK dissociates from the DNA while DNA ligase IV/XRCC4-XLF
complexes mediate religation of DNA. This step occurs after any modification of
DNA is needed by nucleases like Artemis or X-family polymerases. f. The
restoration of fully duplex DNA has occurred. This model is based off of
published data from multiple sources.
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Figure 2. Crystal structural model of the Ku heterodimer. A ribbon diagram in
solid 3-dimensional rendering is depicted with the Ku70 subunit in red and the
Ku80 subunit in orange. a. The non-DNA bound model of Ku is shown here with
drawn lines pointing out the open channel where DNA threads through Ku, βbarrel, α/β domain (vWA), C-terminal arm and the bridge/pillar region of Ku. b.
The DNA-bound form of Ku is depicted and labeled as above in A except duplex
DNA shown in gray. This is modified from (Walker et al., 2001).
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Figure 3. NMR solution structure of the Ku80 C-terminal domain. A ribbon
diagram in solid 3-dimensional rendering is depicted with the Ku80 C-terminal
region colored in yellow. This represents amino acids 566-732 of Ku80. The Nand C-terminal portions of the domain are labeled with letters and a line is drawn
to where the DNA-dependent protein kinase catalytic subunit is known to bind.
This is modified from a Swiss protein data bank viewer file.
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Figure 4. NMR solution structure of the Ku70 C-terminal SAP domain. A ribbon
diagram in solid 3-dimensional rendering is depicted with the Ku70 C-terminal
region colored in magenta. This represents amino acids 561-609. The N- and
C-terminal portions of the domain are labeled. This is modified from a Swiss
protein data bank viewer file.
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Figure 5. Schematic model of the DNA-dependent protein kinase catalytic
subunit. This represents the current 7 angstrom cryo-EM model of DNA-PKcs.
a. the distinct regions of the protein kinase are shown in a side view with the
crown, brow and base being the most predominant regions. b. The central
channel is depicted with duplex DNA entering through it, while a smaller cavity is
thought to be able to accommodate single-stranded DNA. This ssDNA likely
represents a frayed end of the duplex DNA as a part of the NHEJ process. This
figure was adapted from D.R. Williams et al. (2008) Structure 16(3):468-77.
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Figure 6. Schematic for the chemical modification process. Two sets of
samples are used prior to treatment with NHS-biotin. For our experiments, we
have Ku treated with NHS-biotin and Ku pre-bound to a duplex DNA substrate.
Samples are then reacted with 0 μM, 100 μM and 400 μM NHS-biotin. The KuDNA complexes typically yield less overall biotinylation of lysines than the nonDNA bound counterparts. Samples are then processed on SDS-PAGE with
Ku70 and Ku80 bands being excised and in-gel tryptically digested with trypsin.
Peptides are ran on LC-Q tandem mass spectrometry and identified using the
MASCOT algorithm on an error tolerant search selected for biotinylation of
lysines, carbamidomethylation of cysteines and oxidation of methionines which
are a result of the in-gel tryptic digestion procedure.
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II. Materials & Methods
DNA substrates:
Oligonucleotides used in this study are presented in Table 1. Oligonucleotides
were purchased from Integrated DNA Technologies Inc. (Coralville, IA), gel
purified by preparative denaturing polyacrylamide gel electrophoresis, and
annealed to the appropriate complement.
Cell Culture:
Human Ku protein was overexpressed in the Sf9 (Spodoptera frugiperda)
cell culture system. Frozen stocks of Sf9 cells at a concentration of 4x106
cells/mL were thawed, resuspendend in 10 mLs of Grace’s insect cell culture
media (1 liter was formulated with 45.72 g of powdered media, 350 mg of sodium
bicarbonate, 20 mL of 50X yeastolate, 3.3 g of lactalbumin, 10 mL of 100X
penicillin-streptomycin (50 units/mL) and 2 mL of 50 mg/mL gentamicin and then
supplemented
with 10% FBS) and sedimented at 1000 rpm for 10 minutes at 4°C. The cell
pellet was resuspended of media and then plated on a 100 mm dish and grown
at 28°C. Cells became confluent after 3-5 days and were scraped off with a
rubber policeman and split into two 150 mm dishes. After 5 days when the plates
had reached confluence, cells were again scraped and then placed into a 250 mL
spinner flask in 100 mL of media. Cells were grown until a concentration of
1x106 cells/mL was reached and then split to a concentration of 3-5x106 cells per
100 mL of total volume.
Plaque Purification:
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Plaque purified virus was generated from the primary virus. A plaque
assay was performed on the primary virus with a 1:10 serial dilution being done.
Undiluted, 10-1, 10-2, 10-3 and 10-4 dilutions were done in insect media. SF9 cells
were plated into a 6-well plate at a 1x106 cells per well concentration. After 30
minutes all cells were attached, and insect media was removed and 125 µL of
each viral dilution was added to wells and 125 µL of media added to a well as a
control. After viral incubation, the virus was removed and 1.5 mLs of agarose
solution (2% low melting point agarose (melted) mixed with an equivalent volume
of Grace’s insect cell media for a final 1% solution) was added to infected cells.
An additional 1.5 mL of media was added to the top of the agarose after a
cooling period was achieved. A five day incubation occurred and then the 1.5 mL
of media was removed. One mL of of 0.03% neutral red dye (diluted in sterile 1X
PBS) was added to top of the agarose. Neutral red solution was allowed to
incubate for 2 hours and then removed with the plates being inverted and
incubated in the dark overnight. The next day plaques were counted as a
cleared spot in the background of the red dye. Plaques were then amplified as
plaque-amplified virus by picking the cleared spots with glass Pasteur pipettes
and put into 1 mL of media. The virus was allowed to diffuse out of the agarose
overnight, and the tube was sedimented at 8,000 x g on a table top centrifuge to
remove debris. The resulting supernantant was termed the P1 plaque purified
virus.
Plaque assay: Steps for this procedure are very similar to the plaque
purification described above. With higher titers of virus being used greater

38

dilutions of virus were made for the assay in the range of 10-1 to 10-6. Viral
plaques were counted and the titer determined from the following formula:
Titer (pfu/mL) = (# of plaques x 8)/dilution factor. Plaque number was multiplied
by 8 because 125 µL of virus was used to determine the titer in 1 mL (8x 125 µL
= 1 mL). The units of the titer are represented by plaque forming units (pfu) per
milliliter of virus.
Amplification: For viral amplification, SF9 cells were seeded at a
concentration of 5X105 cells per 35 mm plate. After cells were attached to the
plate, 100 µL of plaque purified virus was added to media and plates incubated
for 5 days at 28°C. Media was removed and sterile-filtered. One mL aliquots of
this virus were frozen at -80°C. For the amplification of the secondary virus,
5X105 cells/mL were seeded in 50 mL of complete Grace’s media in a spinner
flask. To this culture, 5X104 pfu/mL of the secondary virus was added. Cultures
in spinner flasks were allowed to spin for 5 days at room temperature. After the
incubation, the entire contents of the spinner flask was poured into a 50 mL
conical vial and sedimented at 1000 x g for 15 minutes at 4°C. The resulting
virus was named the P2 virus and the supernatant put into a new sterile 50 mL
conical tube. These stocks were stored at 4°C and were used to infect larger
cultures. No other virus was amplified past the P3 step. All protein purifications
were from SF9 cells infected with the P2 viral stocks.
Ku protein purification:
Human Ku heterodimer was purified from SF9 insect cells containing
recombinant baculovirus. Transfer vectors were used that contained full length
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Ku80 and a C-terminalhexahistidine [His]6 (LEIEGRHHHHHH) tagged Ku70,
which were provided by Dr. Dale Ramsden (University of North Carolina) as
referenced in (Nick McElhinny et al., 2000). A multiplicity of infection (m.o.i.) of 5
for Ku70 and 10 for Ku80 were used for infection of SF9 cells for a 48 hour time
period. Typically, 125 mLs of Sf-9 cells were co-infected with Ku70 and Ku80
baculovirus and pellet flash frozen in liquid nitrogen and stored for later use at 80º C. Pellets were resuspended in 12 mLs of extract buffer (50 mM sodium
phosphate, 1 M KCl, 7 mM β-mercaptoethanol, 10% glycerol, 0.25% Triton-X 100
and 10 mM imidazole and 1µg/mL of leupeptin, pestatin A and
phenylmethylsulfonylfluoride), and dounce homogenized 20 times on ice.
Lysates were then sonicated at 50% power with 3 x 30 second pulses for three
independent times and then supernatant clarified by centrifugation at 10,000 rpm
for 45 minutes at 4º C. Extracts were then fractionated over a 2 mL Ni-NTA
agarose column and 1 mL fractions were collected. Ku protein was eluted with
Elution buffer (50 mM sodium phosphate, 1 M KCl, 7 mM β-mercaptoethanol,
10% glycerol, 0.25% Triton-X 100 and 350 mM imidazole and 1µg/mL of
leupeptin, pestatin A and phenylmethylsulfonylfluoride). Five µL aliquot of each
fraction was used to measure protein concentration with peak fractions being
collected and pooled together for dialysis. Typically 5-6 mLs of pooled fractions
were dialyzed in a 10,000 MW cut-off dialysis membrane against 1L of 50 mM
HEPES, 50 mM NaCl, absence of protease inhibitors either 0 or 1 mM
dithiothreitol).
EMSAs:
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EMSAs were performed in 20 µl reactions in a buffer containing 50 mM
Tris-Cl, pH 7.8, 10 mM MgCl2, and 50 mM NaCl for redox reactions or in 50 mM
Tris-HCl, pH 7.8, and 50 mM NaCl. Separation was performed with cold 1X TBE
buffer with the gels being pre-cooled at 4°C for EMSAs done with NHS-biotin
modified Ku. Each reaction contained 100 fmol 32P-labeled 30-bp duplex DNA
with the indicated concentrations of Ku for the redox reactions or 100 fmol 32Plabeled 21/34 mer duplex DNA for NHS-biotin modified Ku. Ku was dialyzed
either in the presence or absence of DTT, Triton X-100, and protease inhibitors
prior to use in reaction mixtures. Reactions were mixed and loaded onto a 6%
native polyacrylamide gel. After amino acid chemical modification, Ku was
dialyzed again in the purification dialysis buffer to remove any unwanted reaction
contaminants prior to EMSA. Reactions were carried out for 10 minutes on ice,
loaded onto 6% native polyacrylamide gels and run with cold 1X TBE Buffer.
Gels were vacuum dried and exposed to a PhosphorImager screen and
quantified using ImageQuant software (GE Healthcare Life Sciences, NJ).
Fluorescence Polarization:
Fluorescence polarization experiments were performed using a Cary
Eclipse Fluorescence Spectrophotometer (Varian, CA). Reactions were
performed in a volume of 0.5 ml in a buffer containing 50mM Tris-Cl, pH 7.8, 10
mM MgCl2, 50 mM NaCl and DTT as indicated. Saturation curves were obtained
by titrating Ku into reactions containing 10 nM fluorescein-labeled duplex DNA
ends in the presence or absence of 1 mM DTT and measuring anisotropy at each
Ku concentration. Fluorescence excitation was at 495 nm and emission was
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read at 515 nm, both having band widths set to 5 nm. The formula used for
measurement of the r-value is given here r= I║- I┴/ I║+2 I┴, where fluorescent
intensities are measured with excitation and emission polarizers set parallel (I║)
or perpendicular (I┴) to each other as we have measured for replication protein A
(Andrews and Turchi, 2004). The Ku-DNA binding is represented as the r value
and was calculated as described previously (Arosio et al., 2004).
Heparin-trap:
To determine rates of Ku dissociation from the DNA duplex we employed
a heparin trap assay. The Ku preparation was added to 0.5 ml reactions
containing the fluorscein labeled DNA substrate indicated in the figure legend.
The DNA concentration used was based on DNA termini and was 10 nM for all
dissociation experiments. Pre-treatment of Ku, with 2 mM diamide or 5 mM DTT,
was performed for 15 minutes at room temperature as indicated in the figure
legends. Following formation of the Ku DNA complex, heparin (10 µg) was added
and the change in anisotropy was measured at fixed intervals over a 15 minute
time frame. At each time point, 2 to 5 independent readings were taken with
parallel and perpendicular polarizers, and the calculated r-values were averaged
to give the value for that time point. Each dissociation experiment was
performed three times and the average ± standard deviation is presented.
Tris-Tricine gel electrophoresis:
Electrode and gel buffers were made following this published procedure
for separation of peptides (Schagger, 2006). A 10X stock of anode buffer
containing 1 M Tris and 225 mM HCl, pH 8.9; a 10X stock of cathode buffer
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containing 1 M Tris, 1 M Tricine and 1% SDS, pH 8.25 and a 3X gel buffer with 3
M Tris, 1 M HCl and 0.3% SDS, pH 8.45 were all made and stored at room
temperature. The acrylamide stock solution was made so that a final
concentration of 49.5% acrylamide and 3% bis-acrylamide were dissolved in
water and stored at room temperature with protection from light. A 16%
separating gel was made by addition of the following: 10 mL acrylamide solution,
10 mL 3X gel buffer, 2.4 mL glycerol, with water adjusted to 30 mL total and
polymerized with 100 μl APS and 10 μl TEMED. A 4% stacking gel was made by
addition of the following: 1 mL acrylamide solution, 3 mL 3X gel buffer, with
water adjusted to a 12 mL total volume and polymerized with 90 μl APS and 9 μl
TEMED . After loading of protein gels were electrophoresed for 3.5 hours at a
constant 6 Watts with a cooling water jacket. Protein bands were visualized with
Coomassie blue G-250 and/or silver staining as indicated. Molecular weights of
peptides from Ku were compared to a peptide standard mix (Bio-Rad, CA)
containing the following peptides and their molecular weights: triosephosphate
isomerase 26,625; myoglobin 16,950; α-lactalbumin 14,437; aprotinin 6,512;
insulin b chain, oxidized 3,496 and bacitracin 1,423. Visualization of Ku peptides
or standards was not reached below 5 kDa.
Biotin modification and in-gel tryptic digestion:
Amino acid chemical modification of lysine residues was done with Nhydroxysuccinimidobiotin (NHS-biotin). Purified Ku was modified in the presence
and absence of duplex 21/34 oligonucleotide. Ku (0.5 μM) was preincubated
with or without the addition of 2μM DNA substrate in a protein modification buffer
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containing 50 mM HEPES (pH 7.5), 50 mM NaCl and 2 mM DTT in a 100 μL
reaction volume. DNA binding reactions were incubated for 10 minutes at room
temperature. Biotin modification was performed at final concentrations of 100 μM
or 400 μM NHS-biotin or mock-treated with an equivalent volume of DMSO for
controls. Modification reactions were performed for 25 minutes at room
temperature and stopped with the addition of 10 mM lysine followed by
separation of the Ku 70 and 80 kDa subunits of Ku by 10% SDS-PAGE. The gel
was then stained with Coomassie blue and destained in 10% acetic acid/5%
methanol. Ku70 and Ku80 bands were excised from the gel and dehydrated with
25 mM NH4CO3/50% acetonitrile, treated with 10 mM DTT in 25 mM NH4CO3 at
55ºC for 45 minutes, followed by a treatment with 55 mM iodoacetamide at room
temp. for 30 minutes. Gel pieces were then washed with 25 mM NH4CO3,
dehydrated with 25 mM NH4CO3/50% acetonitrile followed by addition of 440 ng
of bovine trypsin in 25 mM NH4CO3 at a concentration of 12.5ng/μL. Samples
were digested with trypsin overnight at 37ºC. A solution of 50% acetonitrile/5%
formic acid was added the following day with shaking and sonication to release
peptides. Samples were dried under vacuum and 10 μL 1% formic acid was
added prior to LC-MS/MS analysis.
In vitro tryptic protease assay:
The artificial trypsin substrate used for the assay was rhodamine 110, bis
(CBZ-L-alanyl-L-arginine amide) from (Molecular Probes, OR). The rhodamine
fluor was dissolved in DMSO to make a 10 mM stock and then aliquoted into 25
μL stocks and stored at -80º C. Dilutions of stock were made such that a final
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concentration of 100 μM of fluor was used in each reaction. Modified bovine
trypsin sequencing grade (Roche, Switzerland) stocks were made by dissolving
100 μg of powder into 125 μL of 10 mM HCl for a 0.8 μg/μL stock. Trypsin was
diluted to 0, 25, 50 or 100 ng final per reaction. Parameters were set on the Cary
Eclipse fluorescence spectrophotometer (Varian, CA), such that the PMT
detector voltage was set on medium with five replicates on a slit width of 2.5 nm.
The excitation wavelength was set to 498 nm and the emission wavelength set to
521 nm. Kinetic scans were performed after the reactions were initiated at time
zero through 5 minutes. An X-Y pair table was constructed from the kinetic scan
with the Varian software with time (minutes) and fluorescence intensity for each
different concentration of trypsin. A slope was derived from int/min. and these
values were plotted as relative fluorescence on the y-axis versus trypsin
concentration on the x-axis.
Limited proteolysis:
Ku (8-16 μg) was analyzed in reactions containing 50 mM HEPES pH 8.0,
50 mM NaCl and 2 mM DTT. DNA was added to reactions in excess as
described in the biotin modification procedure. The reactions were incubated on
ice for 10 minutes prior to the addition of trypsin as indicated in the figure legends
and then incubated at 37ºC for 45 minutes. The reactions were stopped by
heating the samples to 90ºC for 5 minutes and separated by electrophoresis on
either a 15% SDS-polyacrylamide gel or 16% Tris-tricine polyacrylamide gel.
Protein was either detected with Coomassie blue G-250 or silver stain as
indicated.
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Mass Spectrometry and Peptide Mapping:
Ku (7.5 μg) was subjected to limited proteolysis as described above.
Reactions were terminated by heating to 90°C for 5 minutes and samples were
processed via PepClean™ C-18 spin columns (Pierce, IL) according to the
manufacturer’s protocol. Samples were dried and suspended in 20 μL of 50%
acetonitrile and 0.01% trifluoroacetic acid (TFA). Two μL of each sample was
mixed with 100 fmol of a standard, insulin oxidized B chain (3,494.65 mass), prior
to application onto an Au ProteinChip array (Ciphergen, CA). The matrix αcyano-4-hydroxy-cinnamic acid (CHCA), was prepared as a saturated solution in
50% acetonitrile/0.01% TFA. A total of 1.5 μL CHCA matrix was applied to the
chip and allowed to completely dry. A trypsin control was spotted alone to
identify any non-specific peaks associated from autocatalysis during each
experiment. A Protein Biology System II (PBS II) mass spectrometer (Ciphergen,
CA) was used for MALDI-TOF mass spectrometry. The machine was externally
calibrated each time prior to use with the following peptides (Sigma, MO) and
corresponding m/z values: human angiotensin II (1,046.54), P14R synthetic
peptide (1,533.86), human ACTH fragment 18-39 (2,465.20) and bovine insulin
oxidized B chain (3,494.65). Each individual chip spot was analyzed with a
protocol that ionized 5 times over 20 different areas. Spot positions were
warmed with 2 laser shots at an intensity of 145, with the sensitivity set at 10,
followed by four laser hits at an intensity of 150. Each mass spectrum represents
the sum of the data from 100 laser shots. The source voltage was set at 20,000
V and detector voltage at 1,900 V. Masses were collected up to 8000 Da with
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optimization from 1000 to 5000 Da. Selection of peaks from raw spectra was
done qualitatively using a cutoff of 2.5 for the signal-to-noise (S/N) ratio. Peptide
masses from data were matched with expected masses from the Ku80 (P13010)
or Ku70 (P12956) subunit on the ExPASy Peptide Mass program. Matches were
made up to ±3 Da relative to the observed peptide mass taking into account
enzymatic missed cut sites.
LC-Q Tandem Mass Spectrometry:
Ku (8-16 μg) was subjected to limited proteolysis as indicated above. For
the limited proteolysis reactions, peptides were processed through C-18 spin
columns, dried, and suspended in 10 µL of 1% formic acid. Exhaustive tryptic
digestion as described above was performed on the excised protein bands from
the biotinylation reactions from Coomassie or silver stained gels. Digested
samples were then resuspended in 1% formic acid prior to LC-MS/MS. Data was
obtained by using a Surveyor MS pump and AS3000 autosampler and an LC-Q
Advantage ion trap tandem mass spectrometer (Thermo-Fisher Corp., MA) fitted
with a custom made nanospray source (Gatlin et al., 1998). Peptides were
separated via reverse phase high performance liquid chromatography using a 0.1
x 30 mm, 5 μm 200 Å C-8 (Michrom Bioresources, Inc., CA) trap column and a
0.05 x 150 mm 5 μm, 100 Å, Magic C-8 analytical column/nanospray emitter
packed in-house. The column was equilibrated and samples loaded on the
column in buffer A (0.1% formic acid) at 4 μL/min. Peptides were eluted with a
linear gradient from 2-50% buffer B (0.1% formic acid in acetonitrile) over 80 min
at 0.15 μL/min. Raw MS/MS data was searched using the MASCOT algorithm
search engine and an error tolerant search was performed to identify peptides
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with carbamidomethylations of cysteines, oxidized methionines, and biotinylation
of lysines as modifications to peptides. Positive hits for peptides containing
possible biotinylated lysines were then subjected to further identification by visual
interpretation of the raw MS/MS data. Biotinylated peptides showed an increase
in mass of 226.4 Da on a lysine residue. Qualitatively, data was examined to
determine if protection from biotin occurred in peptides where Ku was prebound
to DNA compared to their biotinylated (or non-biotinylated) counterpart in
samples where Ku was not prebound to DNA. This differentially identified which
lysine residues had changes in solvent accessibility and contact to DNA. In
conditions where Ku was pre-incubated with DNA, the identification of the nonbiotinylated peptides or peptide fragments was performed to ensure that a nonbiotinylation event was not due to a sequence coverage loss of that particular
sequence.
SDS-PAGE and Western Blotting:
All SDS and tris-tricine gels were electrophoresed on a Hoefer SE 260
Mini-Vertical Unit system (GE Healthcare Life Sciences, Piscataway, NJ). Gel
dimensions used were 10 cm by 10.5 cm with a 1 mm thickness. All protein
samples were heated at 90°C for 10 minutes in the presence of SDS sample
buffer (35 mM Tris-HCl pH 6.8, 5% glycerol, 1.7% SDS, 0.2% bromophenol blue
and 1 mM DTT). Heated samples were rapidly centrifuged and loaded onto
either SDS-PAGE or tris-tricine gels. The percentage of SDS-PAGE
polyacrylamide gels differed upon the intended experiment. Typically, 5%
stacker and 10% separating were used for Ku purification and NHS-biotin
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modification, while 5% stacker and 15% separating gels were used for all limited
proteolysis experiments. Gels were electrophoresed at 35 mA for 1 hour and
stopped once the dye front ran off of the gel. Gels were then either stained with
Coomassie blue R-250 or silver stained.
For immunoblotting of Ku, the sample were separated on either type of the
gels and then proteins were transferred onto polyvinylidene fluoride (PVDF)
membrane (Millipore, MA) using the TE 22 Mini Tank Transfer Unit (GE
Healthcare Life Sciences, NJ). Transferring to PVDF was performed at 400 mA
for one hour in a cooling water jacket and CAPS buffer (10 mM 3cyclohexylamino-1-propane sulfonic acid, 10% methanol, pH 10.5). The PVDF
was then removed from the transfer cassette and blocked for 1 hour at room
temperature in buffer containing (2.5% BSA in TBS-T [20 mM Tris-HCl pH 7.5,
170 mM NaCl, and 0.5% Tween-20]). After blocking, all primary antibodies were
diluted to a 1:2000 concentration in blocking buffer and added to the tray with the
PVDF membrane and incubated for one hour. Depending on the experiment, the
following antibodies were used: mouse monoclonal antibodies against Ku70 Ab4 (N3H10) and Ku80 Ab-2 (111) were from (LabVision, CA), goat polyclonal
antibodies against Ku86 (M-20) and rabbit polyclonal antibodies against Ku70 Cterminal domain (C-19) were from (Santa Cruz Biotechnology, CA). After
incubation, the primary antibody was removed and the membrane washed with
TBS-Tween three times for five minute intervals. After the washes, the
secondary antibody goat anti-mouse IgG conjugated HRP or rabbit anti-goat IgG
conjugated HRP (Santa Cruz Biotechnology, CA) or goat anti-rabbit IgG
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conjugated HRP (Bio-Rad Laboratories, CA) was added depending on the
primary antibody used in the experiment. The secondary antibody was incubated
for 30 minutes and then membrane was washed five times in TBS-Tween for 5
minutes each. For visualization of the western blot, a chemiluminescence
reagent (25 mM luminal, 90 mM p-coumaric acid, 100 mM Tris-HCl pH 8.5 and
0.03% hydrogen peroxide in 10 mL water) was poured onto the membrane and
incubated for 1 minute before being removed. Membranes were visualized by a
Fuji LAS-3000 instrument which detected the image from chemiluminescence.
Exposure time with the chemiluminescent reagent depended on the particular
antibody used in the experiment.
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Table 1. DNA substrates used for Ku-DNA binding experiments. The name
designation, oligonucleotide length, how many base pairs of duplex DNA are
present after annealing and which oligos anneal to their complement are
depicted in the table.
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DNA oligonuleotide
1
2
3
4
5
6

Name

5’-GTTTTTAGTTTATTGGGCGCG-3’
5’-CGCGCCCAGCTTTCCCAGCTAATAAACTAAAAAC-3’
5’-GGGATACTCCGTTGCTAGTTTATTGGGCGCG-3’
5’-CGCGCCCAGCTTTCCCAGCTAATAAACTAGCAACGGAGTATCCC-3’
5’-CCCCTATCCTTTCCGCGTCCTTACTTCCCC-3’
5’-GGGGAAGTAAGGACGCGGAAAGGATAGGGG-3’
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Function

21
34
Complement to 21 mer
31
44
Complement to 31 mer
JT/ILH 2.1
JT/ILH 2.2 Complement to 2.1 mer

bp of duplex DNA
14
24
30

III. RESULTS

Human Ku heterodimer:
Human Ku was purified from recombinant baculovirus-infected Sf-9 insect
cells. The transfer vectors for the N-terminal [His]6-tagged Ku70 and full-length
Ku80 were provided by Dr. Dale Ramsden (University of North Carolina Chapel
Hill). Generation of plaque purified virus is described in the Materials and
Methods section. For all infections a multiplicity of infection or MOI of 5 for Ku70
and an MOI of 10 was used throughout all experiments to ensure a 1:1 ratio of
the heterodimer was formed. For a typical purification of Ku a 125 mL pellet of
Ku70/80 baculovirus infected SF9 cells was used. After lysis as described in
Materials and Methods, the lysate (load) was loaded 3-4 times over the Ni+
column to ensure binding and a small aliquot was saved to run on a SDS-PAGE
gel later. After elution from the Ni+ column with 350 mM imidazole elution buffer,
30x1 mL aliquots were collected and then 5 μL from each 1 mL fraction was
analyzed for total protein using a Bradford reagent protein assay. In a typical
purification of Ku, the peak of relative absorbance was contained within 5
fractions after elution. These fractions were pooled together and then dialyzed in
either of the two buffers described in Materials and Methods without protease
inhibitors.
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To examine the purity of the Ku heterodimer relative to contaminants,
samples were analyzed by SDS-PAGE. As shown in Figure 7, lanes 1-4
represent the dialyzed samples of Ku after Ni+ column purification. Lane 4
contains 10 μg of purified Ku heterodimer and reveals that Ku is extremely pure,
yet does contain other contaminating protein bands, which is suitable for our
assays. The amount of other protein contaminants differs depending on the
protein purification prep, and also how much is loaded per lane in an experiment.
The Ku70 and Ku80 subunits are labeled with arrows and correspond to their
anticipated molecular weights based on migration with protein standards.

Oxidation/reduction effects on Ku:
All of the initial pre-steady state experiments were carried out by Brooke
Andrews. Experiments that measured the pre-steady state binding kinetics of Ku
with duplex DNA substrates indicated that the addition of the reducing agent
dithiothreitol (DTT) gave differential fluorescent values that could be fit to two
types of exponential curves (Andrews et al., 2006). In reactions that contained 1
mM DTT, DNA dependent intrinsic fluorescence quenching data fit to a single
exponential decay. Under partially oxidized conditions, (less than 120 μM DTT)
fluorescence data was found to fit to a double exponential decay. This indicated
that a more complex interaction had occurred under partially oxidized conditions
of Ku binding to DNA. Further experiments revealed that this difference in the
intrinsic fluorescence of Ku in the assay must be due to oxidation/reduction.
DNA substrates that could accommodate binding of 2 versus 1 molecules of Ku
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showed the same trends with addition of DTT therefore eliminating a difference
due to a Ku-Ku interaction. Furthermore, substitution of DTT with another
reducing agent, β-mercaptoethanol showed identical exponential decays for
reduced Ku with a single exponential decay. The use of DNA substrates that
contained blocked DNA ends to trap Ku versus non-blocked ends to allow for Ku
sliding along DNA were employed. Therefore, the difference in terminal DNA
structure had no effect between the exponential curves of partially oxidized
versus oxidized Ku. This led to the idea that Ku’s DNA binding activity was truly
influenced by changes in oxidation and reduction status.
To address how redox might affect the ability of Ku to bind duplex DNA,
Ku was purified and dialyzed in buffer without DTT (reducing agent) and the
other half of the purified Ku in dialysis buffer with the addition of 1 mM DTT. The
ability of Ku to bind DNA was examined in an electrophoretic mobility shift assay
(EMSA). Increasing amounts of Ku were incubated with 100 fmol of 32P-labeled
DNA 30 mer and Ku-DNA binding under redox conditions were compared in
Figure 8. The data reveals that under partially oxidized conditions (-DTT)
approximately 60% less binding was observed compared to samples where DTT
was present. Conditions that favor the reduced form of the protein appear to
more readily bind two molecules of Ku. Ku samples that were partially oxidized
and analyzed in EMSA reactions supplemented with 1 mM DTT behaved similar
to the reduced preparation of Ku indicating a reversible redox effect.
To determine if the difference in DNA binding observed between the
oxidized and reduced forms of Ku-DNA complexes was due to binding or
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association with duplex DNA molecules we implemented a solution binding
assay. A fluorescence-based anisotropy assay was employed to measure
oxidized versus reduced forms of Ku binding to duplex DNA substrates in
solution. Fluorescence anisotropy measures the change in fluorescence from a
molecule tumbling in solution in different directions. Typically, a fluorescently
labeled molecule is used and an r-value describing its tumbling in solution is
measured. A protein is then added and this slows down the tumbling of the
fluorescently-labeled probe, such that an increase in the r-value is observed.
Changes in r-value can be measured with increasing concentrations of the
protein or with a fixed amount of protein measured at different time intervals
binding to fluorescently labeled DNA substrates. Figure 9A demonstrates that
there is a marginal difference in binding between the oxidized and reduced forms
of Ku when a 5′-fluorescein labeled 30 mer DNA substrate is used in an
anisotropy binding assay. In the absence of DTT or oxidized conditions, there is
a small decrease in Ku binding compared to the DTT-treated samples. Also, the
maximum r-value for oxidized Ku reaches 0.15 and is increased for reduced Ku
at about 0.23 max r-value.

We repeated the anisotropy experiment with the

21/34 mer duplex DNA substrate, which allows only one Ku molecule to bind and
be trapped due to its blocked end. The results from this experiment are shown in
Figure 9B. Ku under reduced conditions (open circles) has a maximum r-value
where binding saturates at 9 nM Ku with stoichiometric binding, whereas Ku
under oxidized conditions (closed circles) has a greater overall maximum r-value.
Since the overall maximum r-value was greater for Ku under oxidized conditions
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under a single molecule binding event, we interpreted this data to indicate that
oxidized Ku takes on a larger molecular shape.
Additional experiments were designed to examine the dissociation or Ku
falling off of DNA. Anisotropy was used with the addition of heparin, which
sequesters and binds to Ku, such that dissociation of Ku from the DNA occurs.
Once Ku-DNA binding has occurred in the reaction, heparin is added and
anisotropy is measured. The percentage of Ku bound to DNA will then decrease
over time. The results in Figure 10A indicate the dissociation rates of Ku on two
different DNA substrates under reduced conditions where 1 mM DTT was
present. The dissociation rate of the 30 mer substrate (filled circles) was very
slow compared to the rate measured on the 21/34 substrate (open circles). The
difference in dissociation of reduced Ku is reflective of 2 molecules being able to
bind the 30 mer versus a single Ku molecule binding event on the 21/34 mer
substrate. Therefore, it takes a longer period of time for dissociation of 2 Ku
molecules (~80% bound) after 15 minutes to dissociate from the DNA and be
sequestered by the heparin versus 1 Ku (<20% bound) reflected by the change in
anisotropy. Ku-dissociation rates were also measured under oxidized conditions
with the same DNA substrates shown in Figure 10B. Once again, Ku
dissociation from the 30 mer substrate (filled circles) was slower than
dissociation form the 21/34 mer substrate (open circles). However, both
substrates under oxidized conditions exhibited a more rapid dissociation of Ku
compared to their reduced (+DTT) counterparts in Figure 10A. The percentage
of the 30 mer DNA bound after 5 minutes is approximately 40% under oxidized
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conditions while under reduced conditions nearly 90% binding is retained at the
same time interval (filled circles in both figures). A similar dissociation pattern
holds true for the 21/34 mer substrate, but dissociation occurs faster. Under
oxidized conditions where only 20% of Ku is DNA-bound (Figure 10B) versus
~70% under reduced conditions at the same time interval in Figure 10A (open
circles in both figures). To test the reversibility of oxidation and reduction on
dissociation of Ku-DNA complexes, Ku was treated with a reversible oxidizing
agent, diamide. In Figure 10C Ku was treated with diamide in the filled triangles
and dissociation measured by heparin-trap anisotropy on the 30 mer DNA
substrate. An additional set of samples were treated initially with diamide and
then re-reduced with DTT as shown in the filled circles. This part of the
experiment mimicked the slow-type dissociation of Ku in seen in Figure 10A
where dissociation of Ku was measured under reduced conditions as shown in
the filled circles. This increase in the percent of DNA bound indicated a true
reversible effect of Ku under redox conditions. The data thus far has detected a
bona fide reversible redox effect on the mechanism of Ku-DNA binding and most
importantly on dissociation of Ku from duplex DNA.
Thus far, kinetic data revealed a difference in exponential decays between
the oxidized and reduced forms of Ku and anisotropy data showed a major time
difference in dissociation of Ku under redox. The sum of these data pointed to a
multi-step reaction of Ku binding and dissociation from DNA, such that we
hypothesized that a conformational change must occur under redox conditions.
To ensure that the presence of DTT did not alter the ability of trypsin to digest

58

Ku, a fluorescent protease assay was carried out. In Figure 11 results clearly
demonstrate that when concentrations of up to 1 mM DTT are used in an in vitro
protease assay the proteolytic ability of trypsin is not altered on the rhodamine
110, bis (CBZ-L-alanyl-L-arginine amide) substrate. Thus, under our reaction
conditions trypsin enzymatic activity is not altered by concentrations of
dithiothreitol used in our reactions.
To discern the mechanism of a possible conformational change we carried
out a simple limited proteolysis experiment on purified Ku. In Figure 12 Ku was
purified with a final dialysis buffer either with the absence of DTT or the presence
of 1 mM DTT. Limited proteolysis was initiated with trypsin, such that protein
was in great excess. Typically, 15 ng trypsin (533x) to 120 ng trypsin (66.66x) to
amount of excess of Ku protein (8000 ng) were used in reactions. Lanes 1 and 2
show there is no affect on Ku heterodimer stability when it is in the presence of
DTT or left in the oxidized state without addition of trypsin. Lanes 3 and 5 reveal
more generation of tryptic peptides under oxidized conditions than under reduced
conditions in lanes 4 and 6. Corresponding to this digestion event, the Ku70
subunit has a greater generation of peptides than the Ku80 subunit under
oxidized conditions and conversely more protected under reduced conditions.
Therefore, the reduced protease susceptibility of Ku under reduced conditions
provides evidence for an altered conformation of this DNA repair protein.
In order to refine specific structural regions of Ku that might be important
in a redox-dependent conformational change we identified specific proteolytic
fragments using mass spectrometry. MALDI-TOF (matrix-assisted laser
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desorption ionization time-of-flight) mass spectrometry separates peptides based
on their m/z (mass to charge ratio) and gives a relative intensity of all peptides
that have +1 single charge. Predominantly, most peptides detected were found
to be generated under oxidized or treatment without DTT. In Figure 13 the black
traces represent the peptides that get cut under conditions with no DTT, while
red traces show peptides cut under reduced (+DTT) conditions. The majority of
peptides were cut under both oxidized and reduced conditions where the m/z get
completely overlayed with one another. The differences in relative absorbance
are consistent between multiple experiments because an internal peptide
standard is added prior to mixing the sample with the energy absorbing molecule
(EAM). Two peptides that were generated only under reduced conditions are
indicated in Figure 13 with the asterisks above the corresponding m/z. A peptide
with an m/z of 2599.2 Da corresponded to amino acids 302-325 and a larger
peptide with an m/z of 2856.7 Da that corresponded to amino acids 300-325
were identified from the spectra. Upon examination of the peptide sequence, two
tryptic missed-cut sites of Lys317 and Arg318 were contained within both
peptides from the Ku70 sequence. These two peptides contained these
uncleaved amino acids which were generated only under reduced conditions,
and were consequently described by us to be DTT-protected missed cleavage
sites. Therefore, MALDI-TOF MS identified a region in Ku70 that underwent a
redox-dependent conformational change.
To confirm the MALDI-TOF MS findings, we employed the use of tandem
mass spectrometry to positively identify peptides corresponding to the region
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containing the DTT-protected missed cleavage site. A limited proteolytic
digestion at multiple trypsin concentrations was performed and LC-Q MS/MS was
run on samples to confirm what was observed from the MALDI-TOF MS data.
Table 2 presents the sum of LC-Q MS/MS experiments and demonstrates which
peptides were able to be cut under oxidized and reduced conditions and
decidedly the order of residues that were cleaved. Peptides 3-6 (residues 30217, 302-318, 300-317 and 300-318) were all generated under both oxidized (DTT) and reduced (+DTT) conditions. This revealed that the amino acids,
Lys299 and Arg301, were cut indiscriminately independent of DTT, and therefore
represent the initial cut site for trypsin. From this data, we made the conclusion
that enzymatic cleavage at residues Lys317 and Arg318 came secondarily after
Lys299 and Arg301. An examination of peptides 1-2 from Table 2 (319-325 and
318-325) show these peptides are only generated under –DTT or oxidized
conditions and therefore the cut at Arg325 represents a secondary cleavage site.
Peptide 7 (residues 302-325) contains the tryptic cleavage missed cut sites of
Lys317 and Arg318 and was the same peptide identified in the MALDI-TOF
analysis. As it was in the MALDI-TOF MS analysis, this peptide was observed
only under reduced conditions (+DTT). Peptide number 8 which contained amino
acids 300-325 was only observed with MALDI-TOF MS and not LC-Q MS/MS
analysis. Therefore, peptides 7 and 8 confirm the presence of missed cut sites
and DTT-protected Lys317 and Arg318 residues. In the presence of DTT these
sites remain protected, so in reactions performed under reduced conditions the
peptides 317-324 and 318-324 are never observed. Therefore, the observation
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that Lys317 and Arg318 are protected from DTT by trypsin cleavage indicates
that this site represents a focal point for a redox-dependent conformational
change in the Ku70 subunit.
DNA binding effects on Ku:
To date, a complete structural examination of the Ku heterodimer has not
been carried out. We decided to explore the consequences of Ku binding to
duplex DNA substrates in solution and examine how specific domains on both
subunits might change. To look at very simple changes in the Ku-DNA
interaction we employed limited proteolysis. Ku was always examined in purity to
ensure that we had a 1:1 ratio of Ku70:Ku80 subunit prior to digestion. Purified
Ku was incubated with DNA or left untreated and then incubated with limited
amounts of trypsin. A molar excess of DNA was always used in experiments to
ensure that only one Ku molecule was bound per DNA substrate. We anticipate
that the presence of DNA will block trypsin accessibility to Ku, such that less
cleavage occurs under those conditions. The results from a Coomassie-stained
SDS-PAGE gel are depicted in Figure 15 where Ku was bound to the 31/44 mer
duplex DNA substrate. A greater amount of peptides were generated under nonDNA bound conditions shown in lanes 3, 5 and 7 versus DNA-bound Ku in lanes
4, 6 and 8 digested with the same concentration of trypsin. The addition of
duplex DNA in the absence of any protease enzyme (compare lanes 1 and 2)
had no affect on the stability of either the Ku70 or Ku80 subunit. Also, with this
particular purification of Ku protein very few contaminating bands were present.
The DNA substrate, 31/44 mer, employed in this assay contains 24 base pairs of
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duplex, which is capable of binding two Ku molecules. As demonstrated by the
Ku-DNA co-crystal, one molecule of Ku occupies almost all of the 14 base pairs
on the 21/34 mer substrate shown in a space-filling model (Walker et al., 2001).
To eliminate the possibility that an interaction between two Ku molecules
bound to the 31/44 mer substrate caused a difference in the pattern of proteolytic
digestion, we carried out a similar experiment on the 21/34 mer. Although, this
scenario was unlikely because a molar excess of DNA to Ku protein was used in
all binding and proteolysis experiments, we tested this possibility regardless.
Since the 21/34 mer will only allow one Ku molecule to bind, any differences in
digestion would be representative of a DNA-induced protective effect on Ku such
that certain sites are blocked from trypsin accessibility. In Figure 16, 16 μg of Ku
was used per reaction to enhance observations of proteolysis when the 15%
SDS-PAGE was stained with Coomassie blue. Lanes 3, 5 and 7 show a robust
generation of peptides under non-DNA bound conditions with 60, 90 and 180 ng
of trypsin, respectfully. Under DNA-bound conditions at identical trypsin
concentrations in lanes 4, 6 and 8 there are fewer peptides being generated.
However, this would not be due to DNA completely inhibiting trypsin activity
because the Ku80 subunit gets progressively digested with increasing trypsin
concentration under DNA bound conditions in lanes 4, 6 and 8. This cleavage of
Ku80 is likely responsible for the generation of the band seen between the 15
and 20 kDa protein marker. This probably represents the 19 kDa Ku80 Cterminal domain, which is known to be proteolytically sensitive to limited
concentrations of trypsin (Walker et al., 2001). Thus, the difference in generation
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of Ku peptides between non-DNA bound and DNA-bound lanes is due to a DNA
binding event that protects regions of Ku from digestion with protease and not a
Ku-Ku interaction.
One concern was that the unique “blocked-end” DNA substrates (21/34
and 31/44 mer) employed in our studies artificially induce the digestion patterns
that we have observed. To address the possibility that the end-hairpin DNA
structure leads to differential proteolysis, we employed a duplex 30 mer (JT/ILH
2.1/2.2) (shown in Table 1) that does not contain any blocked ends. The 30 mer
duplex substrate was bound in molar excess to ensure all Ku molecules were
bound and limited proteolysis was carried out as in previous experiments and
stained with Coomassie blue in Figure 17. This Ku preparation contained more
contaminants than observed in previous purifications seen in lanes 1 and 2
without trypsin treatment. Major contaminating bands appeared at 50 kDa, 37
kDa, between 20-25 kDa, and 15-20 kDa consistently throughout lanes 1-8.
Once again, more predominant proteolytic patterns were seen in lanes 3, 5 and 7
where Ku was not complexed with DNA. Protection from trypsin was observed
with Ku-DNA complexes in lanes 4, 6 and 8 at identical trypsin concentrations
used compared to the non-DNA bound counterparts. Thus, a similar pattern to
what was observed in Figures 15 and 16 where blocked end hairpin substrates
were used, is also seen with the 30 mer. A side-by-side comparison of digestion
patterns of the 21/34 mer and 30 mer was performed and separated on a 15%
SDS-PAGE gel and stained with Coomassie blue in Figure 18. Identical patterns
of proteolysis were observed between the two different DNA substrates in lanes
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2 and 3 compared to control lane 1 (free Ku) at 30 ng of trypsin. At a higher
concentration of trypsin, identical digestion at the Ku70 and Ku80 subunits
(marked with arrows) was readily apparent between the blocked end substrate in
lane 5 versus the non-blocked end substrate in lane 6. Our observations that KuDNA complexes are partially protected from proteolysis compared to free Ku
could be owed to several intriguing possibilities. The few possibilities are a direct
Ku-DNA interaction that blocks trypsin accessibility could take place or a DNAinduced steric hindrance causing movement of specific regions on Ku. These
would both be predicted to change the proteolytic pattern that we have observed
with the likelihood that the differences observed could be due to a combination of
those two possibilities.
Chemical modification effects on Ku:
To discern specific changes in full-length Ku heterodimer structure, we
decided to employ an amino acid covalent chemical modification assay that can
be done in solution. This assay gave us several advantages to examine Ku
structural changes. It eliminates the problems associated with crystal packing
and the static nature of X-ray crystallography, and allowed us to look at Ku with
both C-terminal domains intact. Also, the particular chemical modifying reagent,
N-hydroxysuccinomidobiotin (NHS-biotin), specifically attaches biotin molecules
to the R-group of lysines. Also, positively charged amino acids, such as lysine
and arginine, typically make contact with the negatively charged DNA in the case
of DNA-binding proteins. Ku also has been shown to use these types of amino
acids for DNA contact. Therefore, modification of lysines serves as a good focal
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point for examination of how solvent accessibility and specific protein-DNA
contacts change under different conditions.
Covalent modification of lysines with the NHS-biotin reagent has revealed
very exciting insight into protein-nucleic acid interactions on a variety of proteins.
The seminal study compared the biotinylation of the HIV reverse transcriptase
(RT) enzyme to the bound RT-viral RNA:tRNA complexes and identified the
differential pattern of biotinylated peptides with tandem mass spectrometry
(Kvaratskhelia et al., 2002). More relevant to the field of DNA repair, the
replication protein A was found to have novel nucleoprotein contacts revealed by
the NHS-biotin modification coupled to tandem mass spectrometry (Shell et al.,
2005). These types of experiments examine the difference between biotinylated
peptides of the free protein and compare them to the biotinylation pattern of the
DNA-bound protein using tandem mass spectrometry to detect an increase in
226.4 Daltons per biotinylated lysine. Some peptides may have more than one
lysine that is capable of being biotinylated. The different lysine residues that get
biotinylated between the free protein and DNA-bound protein give insight into
differences in protein structure and solvent accessibility. Therefore, we decided
to examine the consequence of DNA-binding on the entire Ku heterodimer
implementing this type of methodology in our experiments.
Initially, we wanted to determine the effect of chemical modification on
Ku’s ability to bind duplex DNA. An electrophoretic mobility shift assay (EMSA)
was used to examine the ability of Ku to bind to the 21/34 mer substrate. Prior to
NHS-biotin modification of Ku, we wished to first determine if reaction conditions
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could affect Ku-DNA binding. Ku was mixed with typical EMSA reaction buffer,
modification buffer or with quenching buffer (10 mM lysine) as described in the
Materials and Methods at increasing concentrations of Ku and then ran on a 6%
native polyacrylamide gel in Figure 19. In lanes 4-5, a titration of Ku was added
and increased formation of Ku-DNA complexes marked with the arrow is
observed compared to DNA only in lane 1. Modification buffer had no effect on
Ku-DNA complex formation with increasing amounts of Ku in lanes 8-11. Lanes
14-17 where Ku was mixed with 10 mM lysine, which is used to quench the
unreacted NHS-biotin, showed a slight inhibition compared to control in lanes 25. Quantification of the EMSA showed only a marginal decrease in binding from
the samples mixed with the quenching buffer versus the modification and
untreated samples. Next Ku was reacted with 0 μM, 100 μM and 400 μM NHSbiotin, reactions quenched with lysine and then samples were individually
dialyzed in 50 mM HEPES pH 7.5, 50 mM NaCl. Individual protein
concentrations were measured to ensure equal femtomoles of Ku were loaded
between sets of NHS-biotin reacted and control samples.

32

P-radiolabeled 21/34

mer substrate were mixed with samples and then separated on a 6% EMSA in
Figure 20. Binding of Ku occurred in a concentration-dependent manner in lanes
2-5, while no binding occurred in lane 1 where no Ku was added. In contrast, to
the DMSO-treated 0 μM control set of Ku, a drastic inhibition of Ku-DNA complex
formation was observed in lanes 8-11 at 100 μM NHS-biotin. At a concentration
of 400 μM NHS-biotin Ku-DNA complex formation is not detectable in lanes 1417. Thus, Ku samples that were treated with NHS-biotin and dialyzed still
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showed inhibitory activity versus the dialyzed control. This demonstrates that
chemical modification of critical lysines involved in DNA binding are responsible
for the inhibition of Ku-DNA complexes.
Since concentrations of 100 µM and 400 µM NHS-biotin were inhibitory to
formation of Ku-DNA complexes, we decided to use these concentrations in
biotin modification experiments. A schematic diagram for this procedure is
depicted in Figure 6. This entails binding of Ku to duplex DNA or left unbound,
treatment with NHS-biotin, separation of modified Ku on SDS-PAGE, Ku70 and
Ku80 bands are cut out and exhaustively digested with trypsin in-gel. Separation
of biotin-modified Ku peptides is then carried out by HPLC-driven tandem mass
spectrometry so peptides undergo collision-induced dissociation (CID) and
biotinylated peptides are identified. Raw data obtained from the LC-MS/MS
experiments is searched against the Swiss-Prot database using the MASCOT
algorithm. Additionally, DMSO-treated control sets of Ku are completely
processed and the resultant peptides are searched against the error-tolerant
settings to sort out any peptides that are incorrectly identified as containing the
biotin modification. After multiple experimental runs at different concentrations of
NHS-biotin, Table 3 was derived for changes in biotinylation of Ku peptides.
Table 3 depicts the amino acids of the peptide, the particular biotinylated lysine
residue, which subunit of Ku the modification occurs on, and whether the
biotinylation occurs in the presence or absence of DNA. The sequence of
peptides from Table 3 is based off of the numbering system used in the
published Ku crystal structure (Walker et al., 2001). All experiments were done
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with the 21/34 mer substrate and repeated with the 31/44 mer DNA substrates to
identify true changes in biotinylation status and eliminate any lysine residues
from our data set that are periodically biotinylated. Verification of all peptides in
Table 3 was performed by assignment of b and y ions to raw MS/MS data and is
presented in Appendix 1.
Several interesting biotinylation events on the Ku heterodimer were
uncovered with respect to binding to duplex DNA. Peptide 1 in Table 3
corresponds to 302-318 of the Ku70 subunit. Within this peptide the biotinmodified residue is K317, which is always modified under both DNA-bound and
free conditions. This amino acid sits in the bridge-pillar region of Ku in the crystal
structure. The R-group of K317 projects outward from the pillar and is very
solvent accessible for biotin modification regardless of DNA-binding as shown
modeled in the crystal structure in Figure 21. Interestingly, this region was
previously described by our lab as the site where the reduced form of Ku had a
DTT-protected site from trypsin and was the proposed area of redox-dependent
conformational change. (Andrews et al., 2006). From the sum of all the peptides
analyzed from biotin modification/tandem mass spectrometry experiments,
peptides that were biotinylated under both free and DNA-bound conditions were
most predominant. The open shape of Ku and the manner in which it binds DNA
through it’s preformed channel is consistent with the mass spectrometry data
revealing the majority of peptides containing lysine are always accessible to
NHS-biotin. Peptide 2, which covers residues 326-339 of Ku70, from Table 3
was determined to be biotinylated on K331 and was found to be uniquely
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modified only under conditions where DNA was not present in the reaction. This
indicates that duplex DNA blocks the accessibility of NHS-biotin from
modification of this peptide. Biotinylated K331 resides on the same peptide as
another lysine residue, K338, that was reported to contact a sugar on DNA in the
Ku-DNA co-crystal (Walker et al., 2001). The biotinylation status of K338 was
not consistent when compared with the 21/34 and 31/44 mer DNA substrates.
However, K338 was always biotinylated in the absence of DNA. This
unexpected result could be from the Ku-DNA complex equilibrium or from Ku
translocation along the DNA molecule. Figure 22 depicts K331, which is in the
bridge-pillar region of the Ku70 subunit. This residue very likely makes contacts
with sugar or phosphate on DNA as observed with the close spatial proximity to
the DNA binding region from the crystal structure model.
The most intriguing result that the solvent accessibility studies on Ku-DNA
binding determined were the biotinylation events on peptides 3 and 4 in Table 3.
Peptides 3 and 4 were found to be biotinylated only in the absence of DNA.
Peptide 3 was within amino acids 527-542 with a biotinylation on K539, while
peptide 4 was within residues 576-586 with a biotinylation on K582.
Remarkably, both K539 and K582 map to the unstructured region in the Cterminal domain of the Ku70 subunit. These residues are both absent from the
Ku crystal structure complexed with DNA. However, the K582 residue is present
in the non-DNA bound crystal structure, while K539 was not resolved. The site
where K582 is biotinylated in the Ku70 CTD in the absence of DNA is modeled in
Figure 23. This suggests that the K539 residue is in a highly flexible region and
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possibly very mobile in solution. K539 and K582 could both potentially interact
with DNA and then get blocked from biotinylation by NHS-biotin when duplex
DNA is present in the reaction mixture. These two amino acids are comprised
within a region of Ku70 C-terminal domain referred to as the SAP (SAF-A/B,
Acinus and PIAS) domain, which has been reported to contain a DNA binding
motif (Aravind and Koonin, 2001). The SAP domain is comprised within a small
family of other proteins involved in chromosomal organization and DNA repair.
We anticipated that there would be changes in the biotinylation status of
the Ku80 C-terminal domain of Ku. Identification of Ku80-specific peptides was
performed with the MASCOT program and then biotinylated peptides from nonDNA bound set were compared to the DNA-bound set. The only change in
biotinylation was on peptide 5, amino acids 261-271, containing K265 in Table 3.
This residue was previously identified in the Ku crystal structure to make contacts
with the sugar and phosphate in the DNA. We have modeled this lysine in the
Ku crystal structure in Figure 24 with the R-group projected towards the DNA.
This represented a nice internal control for our data set since we know that it
would likely be blocked from NHS-biotin modification by the presence of DNA.
We examined the entire set of biotinylated peptides from the Ku80 C-terminal
region and could not find any differences. These peptides are represented by
peptides 6-8 in Table 3. The Ku80 C-terminal region has a very solvent accessible structure representing a disordered protein module. Therefore, it was
not entirely surprising that we were not able to detect any differences using this
chemical modification assay.
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In anticipation that the C-terminus of Ku80 would undergo a DNA-induced
steric hindrance change, we sought additional methods to answer this question.
Since, the chemical modification assay detects very specific differences related
to protein structure we employed an assay that examined more global
differences in DNA-induced structural changes in Ku. Once again, we used
limited proteolysis of DNA-bound and free Ku as a measurement of DNA-induced
structural changes. The resultant SDS-PAGE gels were transferred and probed
as a western blot with site-specific antibodies to various regions of both Ku70
and Ku80 subunits. Figure 25 shows the different domains in the Ku subunits
and the amino acid epitopes that the antibodies recognize in the C-terminal
regions of Ku70 and Ku80. Antibodies used in experiments are contained within
the Ku70 and Ku80 CTDs. The results in Figure 26 were probed with the clone
111 antibody, which recognizes amino acids 610-705 of Ku80. This antibody
detected a clear pattern of proteolysis that was dependent on DNA in the
reaction. As in previous experiments, lower molecular weight contaminants
showed up in the control lanes 1 and 2 around 50 and 70 kDa, which were
recognized by the antibody. These persisted throughout the experiment except
at higher concentrations of trypsin. A very intense band of protein at 19 kDa,
which is dependent on trypsin, was recognized by the clone 111 antibody and
appears in lanes 3-8. This fragment was interpreted to be the 19 kDa trypticsensitive Ku80 C-terminal domain, approximately amino acids 566-732 and is
labeled as such in the figure. This is the very portion of Ku that was removed
prior to crystallization (Walker et al., 2001). The apparent intensity of this band
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remained constant even at the highest concentration of trypsin used in lanes 7
and 8, and is never dependent on the presence of DNA in the reaction.
However, a unique set of doublet bands that is recognized by the Ku80 CTD
antibody between the 20 and 25 kDa marker is detected only in the absence of
DNA in lanes 3, 5 and 7 in Figure 26. This set of bands were clearly not
detectable when Ku was pre-bound to the DNA substrate in lanes 4, 6 and 8.
Since this doublet is able to be recognized by the clone 111 antibody and is of
higher molecular weight than the 19 kDa fragment, we can conclude these
fragments contain sequences which are N-terminal to amino acid residue 566 on
the Ku80 subunit. Therefore, we conclude that the Ku80 C-terminal region
undergoes a DNA-dependent conformational change.
We sought to determine if any very small molecular weight peptides in the
range of 2-15 kDa were generated upon Ku digestion in the presence or absence
of DNA. Ku subjected to limited proteolysis were separated by electrophoresis
on a 16% Tris-tricine gel and the gel stained with Coomassie blue as described
in the Materials and Methods section. Tricine-PAGE revealed the presence of
peptides with MW’s below 15 kDa in Figure 27. A unique Ku peptide which
migrated with an apparent molecular mass of 10 kDa was observed only with
free Ku in lanes 3, 5 and 7. In reactions where Ku was bound to the 21/34 DNA
the 10 kDa band was not observed in lanes 2, 4 and 6. Also, very visible
throughout lanes 1-8 are small molecular weight peptide contaminants slightly
below 20 kDa through 27 kDa. Also visible in Figure 27 is the appearance of a
set of doublet bands that appear in lanes 3, 5 and 7 at around 37 kDa
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preferentially in the absence of DNA. Interestingly, a band at ~18 kDa increased
in intensity with trypsin concentration in lanes 4, 6 and 8 only in the presence of
DNA. This data suggested that DNA binding either inhibited trypsin cleavage
generating the 10 kDa band or stimulated secondary cleavage within the 10 kDa
peptide such that it was degraded into smaller peptides. Additionally, we desired
to test if the loss of the 10 kDa band upon DNA binding was the result of using
the blocked-end 21/34-mer substrate, we performed an experiment using the
duplex 30-mer (no blocked ends) and observed identical results where
generation of the 10 kDa band is reduced upon DNA binding in Figure 28. This
event was readily observable in the background of a Ku preparation that
contained a fair amount of low molecular weight contaminating peptides present
in lanes 1-2 in the absence of trypsin. The appearance of the 37 kDa doublet
band is again present in lanes 3, 5 and 7 in Figure 28 in the absence of DNA.
This result was consistent with Figure 27 where the appearance of the 10 kDa
band always coincided with the generation of the 37 kDa peptide fragment.
Thus, we concluded that the generation of the 10 kDa peptide was due to a local
change in DNA movement or conformation and not on the presence of blocked or
free duplex DNA ends.
We wished to identify the 10 kDa band as Ku70 or Ku80-specific in origin.
To this end, we carried out limited proteolysis and separated samples on tristricine gels which were transferred to a membrane to be probed with a variety of
site-specific antibodies against Ku70 and Ku80. An antibody against the far Cterminal region of Ku70 (within the final 30 residues) reacted with the 10 kDa
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peptide demonstrating that this peptide encompasses the extreme C-terminus of
Ku70 in Figures 25 and 29. The enhancement of antibody detection revealed
that the 10 kDa band was also generated in reactions with Ku-DNA complexes
and was dependent on the degree of digestion with protease. In all experiments,
with limited trypsin concentrations, the appearance of this peptide was
significantly reduced upon DNA binding. Also, the C-19 antibody detected the 37
kDa band in Figure 29 in lanes with no DNA, indicating this doublet contained
sequences comprising the far C-terminus of Ku70. The dynamic nature of the
DNA binding reactions could account for the inability to completely abrogate the
generation of the 10 kDa band or that the change or blocking of trypsin
accessibility is only partially reduced under these conditions.
While the tris-tricine electrophoresis in Figures 27-29 resolved the resolution
of low molecular weight fragments, it was apparent that there were DNA–
dependent differences in the generation of higher molecular weight tryptic
fragments. Experiments repeated and separated via traditional SDS-PAGE then
probed with the Ku70 C-19 C-terminal antibody are shown in Figure 30 and
revealed similar digestion patterns. A second doublet was readily observed at
approximately 37 kDa (denoted by asterisk) which again was dramatically
reduced in intensity in reactions where Ku was bound to DNA. This was
interpreted to be the same doublet recognized by Coomassie staining in Figures
27 and 28 dependent on the absence of DNA from the reaction. To determine
the identity of the 37 kDa doublet, an additional 15% SDS-PAGE gel was run and
probed with a different Ku70 antibody (N3H10) which recognizes amino acids
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506-541 in Figures 25 and 31. The single and double asterisks refer to the
generation of doublet peptides cut from Ku under non-DNA bound conditions at
37 kDa and 25 kDa, respectively. Therefore, the 10 kDa band represented a
partial product from the 37 kDa band and must contain amino acids comprising a
sequence after amino acid 541, since the 25 kDa band is only recognized by the
N3H10 antibody. Thus, the 10 kDa band represents the extreme C-terminal
portion of the Ku70 SAP domain and a reduction of this peptide is observed
under DNA-binding of Ku.
To precisely identify the sequence of the 10 kDa peptide that comprises the
extreme C-terminus of Ku70, we excised the 10 kDa band and performed an ingel tryptic digestion. Following LC-MS/MS analysis which detected 13 different
peptides corresponding to the Ku70 subunit shown in Table 4. The majority of
the peptides (8 out of 13) mapped to the C-terminal region of Ku70 covering
amino acids 545-605, represented by peptides 6-13 in Table 4. The other
peptides discovered mapped to five separate regions of Ku70 and appeared only
one time each in the MASCOT database search with the exception of peptide 1,
which appeared twice. This more random appearance of peptides is likely due to
multiple usage of C8 packed HPLC columns from previous LC-MS/MS runs. The
list of peptides in Table 4 represents the sum of all the peptides detected.
Addition of the corresponding molecular weight of the amino acids 545-605 that
are detectable in the C-terminal region a mass of 7.33 kDa is derived. It is quite
possible that additional peptides could have been generated from trypsin
cleavage both N- and C-terminally from amino acids 545-605 on Ku70, but not
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observed. The last four amino acids HFQD (606-609) of Ku70 were not
detectable by mass spectrometry as a peptide alone or as part of a larger
peptide. Also, N-terminal of residue 545, VTKRK could also be cleaved at two
sites to generate a di- and tripeptide. This particular peptide could be cleaved
into smaller products that would be too small to be detected or more likely these
peptides were not trapped on the C8 material and flowed through to the waste
from the HPLC during the sample run on the LC-MS/MS. Another possible
peptide that could have been generated, ELVYPPDYNPEGK (amino acids 527539), was also not detected. Although these three peptides are in linear
proximity to the Ku70 C-terminal peptides that comprised the 10 kDa band they
were not detectable. The wide variety in difference between the techniques of
tris-tricine PAGE and tandem mass spectrometry can account for the difference
in molecular weights observed between experiments.
Western blots probed with antibodies against the Ku70 C-terminus revealed
a robust difference in the generation of the 10 kDa band between free and DNAbound Ku. The C-19 antibody recognizes the far C-terminus of Ku70 depicted in
Figure 25 and detected two bands that are more predominant in intensity when
Ku is not bound to DNA, yet is detectable with Ku-DNA complexes in Figure 29.
This doublet corresponds to a molecular weight of approximately 7 and 10 kDa,
respectively. This experiment also utilized higher amounts of trypsin and Ku
protein than those used in Figures 27 and 28. The doublet that is recognized by
the antibody appears in both lanes containing free and DNA-bound Ku, and the
intensity markedly increases with increasing amounts of trypsin. The same result
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is duplicated on an SDS-PAGE gel probed with the same antibodies in Figure 30.
Even though we could not detect the Ku70 C-terminal peptide,
ELVYPPDYNPEGK, from in-gel tryptic digestion of the 10 kDa band, the majority
of this peptide represented a critical change in biotinylation in the Ku70 CTD
depicted in Table 3. Therefore, this data indicates that the Ku70 C-terminal
domain appears to reposition itself by scaffolding or form new secondary
structural features when it contacts duplex DNA.
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Figure 7. Purification of human Ku heterodimer. Full-length Ku was
overexpressed in insect cells and subjected to Ni+ column affinity
chromatography as described in Materials and Methods. Lanes 1-4 show 1, 2.5,
5 and 10 μg, respectively of dialyzed/Ni+ purified Ku. Proteins are detected with
Coomassie blue staining.
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Figure 8. Ku-DNA complex formation under DTT stimulation. Increasing
concentrations of Ku that contained 1 mM DTT (lanes 1-6) or without DTT (lanes
7-12) in the final dialysis pool were mixed with 32P-labeled JT/ILH 2.1/2.1 duplex
DNA as described in Materials and Methods. Incubations were performed with
no Ku (lanes 1 and 7) and 12.5, 25, 37.5, 50 and 100 nM Ku (both lanes 2-6 and
8-12). Samples were run on a 6% native-PAGE and processed as described in
Materials and Methods. Free DNA and DNA-bound Ku positions are indicated on
the left side of EMSA.
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Figure 9. Anisotropy of redox-stimulated Ku-DNA binding. A. analysis of Ku
binding in solution to a 30 mer (JT/ILH 2.1/2.2). Reactions were performed from
a Ku prep in which the final dialysis pool contained no DTT (filled circles) or with
1 mM DTT added (open circles). Anisotropy was performed, calculated and
plotted versus Ku concentration as described in Materials and Methods. Each
concentration point is representative of three separate experiments of the
average ± S.D. B. analysis of Ku binding in solution to the 21/34 mer hairpin
DNA. Both experiments in A and B were performed by Brooke Andrews.
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Figure 10. Dissociation of Ku-DNA complexes is affected by redox. A.
Dissociation of Ku-DNA complexes were all performed with 1 mM DTT. A
heparin trap assay anisotropy variant was used to examine dissociation rates of
Ku from DNA as described in Materials and Methods. Dissociation of Ku-DNA
complexes was measured in solution on a 30 mer (JT/ILH 2.1/2.2) in (filled
circles) or 21/34 mer (open circles). The percent of DNA bound was calculated
and plotted versus time. The data were fit to double exponential decays, and
residual values presented below each panel. B. Dissociation of Ku-DNA
complexes was measured in solution without DTT and performed as described
above. C. Diamide oxidation and DTT supplementation effect on Ku-DNA binding
on a 30 mer (JT/ILH 2.1/2.2). Ku was treated with 2 mM diamide for 15 min.
(filled triangles) and then re-reduced with 5 mM DTT for 15 min. (filled circles)
and Ku-DNA dissociation measured as described in above. All experiments in AC were performed by Brooke Andrews.
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Figure 11. In vitro tryptic protease assay. 0, 25, 50 or 100 ng of trypsin was
added to reactions containing 100 μM of the rhodamine 110, bis (CBZ-L-alanyl-Larginine amide) substrate. Reactions were performed with no DTT (filled circles)
or 1 mM DTT (open circles). Fluorescence was measured and data plotted as
indicated in the Materials and Methods section.

87

R elative Flu oresce nce

30

25

20

15

10

no DTT
1 mM DTT

5

0
0

20

40

60

Trypsin (ng)

88

80

100

120

Figure 12. SDS-PAGE analysis of a limited tryptic digestion of DTT-stimulated
Ku. 8 µg of Ku was reacted with no trypsin (lanes 1 and 2), 12.8 ng trypsin
(lanes 3 and 4) or 32 ng trypsin (lanes 5 and 6) as described in Materials and
Methods. Ku in lanes 1, 3 and 5 had reactions that contained no DTT, while a
final concentration of 1 mM of DTT was added prior to initiation of digestions in
lanes 2, 4 and 6. Samples were separated on a 10% SDS-PAGE and stained
with Coomassie blue.
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Figure 13. MALDI-TOF MS analysis of DTT-stimulated tryptically digested Ku
peptides. 8 µg of Ku was subjected to limited proteolysis with trypsin in solution,
processed for mass spectrometry analysis and peptides identified as described in
Materials and Methods. A representative 32 ng trypsin treatment is depicted in
these spectra where peptides generated under conditions without DTT (black
trace) or in presence of DTT (red trace) are depicted with their corresponding m/z
ratios. Peaks with stars are only cut under reduced (DTT-treated) conditions.
Mass spectra was normalized to internal peptide standards as described in
Materials and Methods. A similar trend was seen from data in three independent
experiments and multiple concentrations of trypsin.
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Figure 14. Crystal structure of bridge-pillar region in Ku where redox-dependent
changes occur. A ribbon diagram in solid 3-dimensional rendering is depicted
with the Ku70 structure depicted in red, while Ku80 is shown in orange in a
ribbon diagram model. The peptide generated in DTT-stimulated trypsin
reactions comprising the amino acid sequence of 301-324 is highlighted in green.
All Ku70 side chains of Lys317, Arg318, Lys299, Arg301 and Arg325 are
depicted in blue. Ku80 amino acid side chains of Cys493 in navy and Trp276 is
depicted in magenta.
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Figure 15. Limited proteolysis of free and DNA-bound Ku heterodimer. 8 µg of
Ku was either left free or bound to saturating amounts of 31/44 DNA substrate
(indicated by – and +) as described in the Materials and Methods. Proteolysis by
trypsin was initiated by addition of 15 ng (lanes 3-4), 30 ng (lanes 5-6), and 60 ng
(lanes 7-8) or no trypsin (lanes1-2) and the reaction carried out for 45 minutes at
37ºC. Samples were run and then loaded onto a 15% SDS-PAGE gel and
stained with Coomassie blue G-250 to observe peptides generated by tryptic
cleavage. Positions of the undigested 70 kDa and 80 kDa Ku subunits are
indicated with arrows.
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Figure 16. Single-Ku molecule limited proteolysis on a DNA substrate. Identical
conditions used in Figure 15 were examined with Ku binding to the 21/34 DNA
substrate (indicated by – and +). Proteolysis by trypsin was initiated by addition
of 60 ng (lanes 3-4), 90 ng (lanes 5-6), and 180 ng (lanes 7-8) or no trypsin
(lanes1-2) and the reaction carried out for 45 minutes at 37ºC. Samples were
run and stained as described in the previous figure. Positions of the undigested
70 kDa and 80 kDa Ku subunits are indicated with arrows.
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Figure 17. Limited proteolysis on a “non-blocked end” DNA substrate. Identical
conditions used in Figure 15 were used to examine Ku binding to the JT/ILH
2.1/2.1 DNA substrate. Proteolysis by trypsin was initiated by addition of 15 ng
(lanes 3-4), 30 ng (lanes 5-6), and 60 ng (lanes 7-8) or no trypsin (lanes1-2) and
the reaction carried out for 45 minutes at 37ºC. Samples were run and stained
as described in the previous figure. Positions of the undigested 70 kDa and 80
kDa Ku subunits are indicated with arrows.
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Figure 18. Limited proteolysis of a “non-blocked end” versus “blocked end” DNA
substrate. Identical conditions used in Figure 17 examined Ku binding to the
21/34 blocked end DNA substrate next to the 30 mer DNA substrate with both
free ends. Proteolysis by trypsin was initiated by addition of 30 ng (lanes 1-3) or
60 ng (lanes 4-6) and the reaction carried out for 45 minutes at 37ºC. Samples
were run and stained with Coomassie blue as described in the previous figure.
Positions of the undigested 70 kDa and 80 kDa Ku subunits are indicated with
arrows.
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Figure 19. Biotinylation reaction buffer conditions do not affect Ku-DNA binding.
An EMSA was run with purified Ku treated with 0 µM NHS-biotin, modification
buffer (50 mM HEPES pH 8.0, 50 mM NaCl) or quenching buffer (10 mM lysine).
For each concentration set of NHS-biotin 0, 100, 200, 400 and 800 fmol of Ku
were mixed with 100 fmol of a 32P-labeled 21/34 DNA substrate and reactions
carried out and loaded onto a 6% Native gel as described in Materials and
Methods.
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Figure 20. NHS-biotin modification directly inhibits Ku-DNA binding. An EMSA
was run with purified Ku treated with 0 µM, 100 µM or 400 µM of NHS-biotin. Ku
was allowed to react with given NHS-biotin concentrations as described in
Materials and Methods and then subjected to dialysis against 50 mM HEPES pH
8.0, 50 mM NaCl to remove reaction byproducts. Protein concentration was
measured prior to reaction in EMSA post dialysis. Reactions were carried out as
described in the previous figure.
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Figure 21. Biotinylation occurs independent of DNA-binding at K317. A ribbon
diagram in solid 3-dimensional rendering is depicted with the Ku70 structure
depicted in yellow. The 21/34 DNA substrate is depicted in (red/green) with the
Ku80 subunit (blue) A peptide containing biotinylated K317 (orange) from the
Ku70 subunit (yellow) is detected with Ku alone and Ku-DNA complexes
according to Table 3.
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Figure 22. Biotinylation occurs at K331 dependent on DNA-binding. Modeling
and coloring of Ku subunits and DNA was performed as described in Figure 21.
A peptide containing biotinylated K331 (orange) from the Ku70 subunit (yellow)
was only found under non-DNA bound conditions according to Table 3.
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Figure 23. Model of biotinylation changes on the Ku70 C-terminal domain.
Amino acid residues 561-609 are depicted in this NMR structure in magenta.
Amino acid residues 535-560 are unstructured and are not present in the
structure. Two amino acid residues K539 and K582 were found to be
preferentially biotinylated under non-DNA bound conditions depicted in Table 3.
The R-group of K582 is depicted in yellow in the structure.
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Figure 24. Biotinylation occurs at K265 dependent on DNA-binding. Modeling
and coloring of Ku subunits and DNA was performed as described in Figures 21
and 22. A peptide containing K265 (orange) from the Ku80 subunit (blue) was
found to only be biotinylated in the absence of DNA according to Table 3.
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Figure 25. Epitope mapping of Ku70 and Ku80-domain specific antibodies. A
diagram representing the linear amino acid sequences of Ku70 (top) and Ku80
(bottom) is depicted. The Ku70 leucine zipper domain is colored in blue and the
C-terminal SAP (SAF-A/B, Acinus and PIAS) domain is in red. The Ku80 Cterminal DNA-PKcs interaction domain (CTD) is in green, and on both subunits
the Ku heterodimerization domains are colored in yellow. Antibodies that
recognize an epitope against the C-terminus of Ku70 are diagrammed: the
N3H10 antibody recognizes amino acids 506-541 and the C-19 recognizes some
amino acids within residues 579-609. An antibody against the C-terminus of
Ku80 (Ab2-clone 111) recognizes amino acids 610-705. Numbered tick marks
represent 100 amino acids for each protein.
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Figure 26. Protection of Ku80-specific peptides with Ku-DNA complexes. DNA
binding reactions and proteolysis were performed identically to Figure 11. 15 ng
of trypsin was used in (lanes 3-4), 30 ng (lanes 5-6), and 60 ng (lanes 7-8) or no
trypsin (lanes1-2) and the reaction carried out for 45 minutes at 37ºC. Samples
were separated on a 15% SDS-PAGE gel and transferred to a PVDF membrane
and probed with an anti-Ku80 clone 111 antibody that recognizes the C-terminus
of Ku80 amino acids 610-705. Positions of undigested Ku80 and proteolyticsensitive 19 kDa Ku80 C-terminal region are identified with arrows
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Figure 27. Limited proteolysis of Ku on a “blocked-end DNA substrate”. 16 µg
of Ku was either left free or bound to saturating amounts of 21/34 DNA substrate
(indicated by – and +) as described in the Material and Methods. Limited tryptic
proteolysis was initiated by the addition of 15 ng (lanes 3-4), 30 ng (lanes 5-6),
and 60 ng (lanes 7-8) or no trypsin (lanes 1-2) and the reaction carried out for 45
minutes at 37ºC. Proteolytic Ku digests were separated on a 16% tris-tricine gel
and stained with Coomassie blue G-250 to visualize low molecular weight
peptides. The 10 kDa peptide is indicated with an arrow.
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Figure 28. Limited proteolysis of Ku with a “non-blocked end” DNA substrate.
16 µg of Ku was either left free or bound to saturating amounts of JT/ILH 2.1/2.2
DNA substrate (indicated by – and +) and proteolysis was initiated by addition of
45 ng (lanes 3-4), 90 ng (lanes 5-6), and 180 ng (lanes 7-8) or no trypsin (lanes
1-2) with the same incubation conditions described above.
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Figure 29. Detection of the 10 kDa peptide by Western blot from tris-tricine
PAGE. 16 µg of Ku was either left free or bound to saturating amounts of 21/34
DNA substrate (indicated by – and +) and proteolysis was initiated by addition of
45 ng (lanes 3-4), 90 ng (lanes 5-6), and 180 ng (lanes 7-8) or no trypsin (lanes
1-2) with the same incubation conditions described above. Samples were
separated on a 16% tris-tricine gel and transferred to PVDF membrane and was
probed with the anti-Ku70 C-19 antibody for detection of smaller Ku70 C-terminal
peptides.
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Figure 30. Detection of the 10 kDa peptide by Western blot from SDS-PAGE.
Samples were prepared as described in Figure 27 and separated on a 15% SDSPAGE gel and transferred to PVDF and probed with the anti-Ku70 C-19 antibody
which recognizes the far C-terminal region of Ku70. The position of the 37 kDa
tryptic cleavage products is indicated with one asterisk and 10 kDa peptide with
an arrow.
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Figure 31. Detection of the 10 kDa peptide precursor peptides by Western blot
from SDS-PAGE. Samples were separated on a 15% SDS-PAGE gel and
transferred to PVDF and probed with an anti-Ku70 N3H10 antibody which
recognizes the more N-terminal part of the Ku70 C-terminal portion (amino acids
506-541). The position of the Ku70 subunit and 10 kDa peptide are indicated
with arrows in Western blots. The positions of 37 kDa tryptic cleavage products
are indicated with one asterisk and the 25 kDa tryptic cleavage product is
denoted by two asterisks.
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Table 2. MS/MS analysis of Ku peptides generated under reduced conditions. A
unique array of peptides that were cut in limited proteolysis reactions in the
absence of DTT are depicted here with corresponding masses, amino acid
sequences of peptides from the Ku70 subunit and the number of tryptic missed
cut sites. The – and + refer to the absence and presence of peptides in
proteolytic reactions with DTT.
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peptide
mass
Ku70 peptide
1
809.40
319-325
2
965.50
318-325
3
1650.85
302-317
4
1806.95
302-318
5
1908.00
300-317
6
2064.10
300-318
7
2598.34
302-325
8*
2856.7
300-325
*only observed in MALDI-TOF analysis

Missed cut sites
0
0
0
1 (317)
1 (301)
2 (301,317)
2 (317,318)
3(301,317,318)
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Trypsin activity
+DTT
-DTT
+
+
+
+
+
+
+
+
+
+
+
+
-

Table 3. MS/MS analysis of Ku amino acid chemical modification. An in-gel
tryptic digestion procedure was performed on Ku70 and Ku80-specific bands that
had undergone NHS-biotin modification. Samples were run separately by LCMS/MS to identify differences in biotinylation of lysine residues with free and
DNA-bound Ku as described in Materials and Methods. Individual columns show
the peptide sequence, corresponding amino acids, subunit identity and individual
biotinylated residues. The presence of a biotinylated lysine is indicated by a (+)
and a non-biotinylated lysine with a (-) in columns.
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Ku
amino
Peptide
subunit
acids
Biotin (K) -DNA
1
TFNTSTGGLLLPSDTKR
Ku70
302-318
K317
+
2
QIILEKEETEELKR
Ku70
326-339
K331
+
3*
ELVYPPDYNPEGKVTK
Ku70
527-542
K539
+
4*
FTVPMLKEACR
Ku70
576-586
K582
+
5** IAAYKSILQER
Ku80
261-271
K265
+
6
IKTLFPLIEAKK
Ku80
533-544 K534/K543
+
7
FNNFLKALQEK
Ku80
655-665
K660
+
8
KFLAPK
Ku80
703-708
K703
+
*Peptides that map to regions not present in the crystal structure that display
differential (K) biotinylation
**Residue known to make contact with phoshate in DNA and sugar from crysta l structure
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+DNA
+
+
+
+

Table 4. MS/MS analysis of the 10 kDa peptide. Protein gel bands from an
experiment representative of Figure 24 (lanes 3, 5 and 7) were excised and
subjected to an in-gel tryptic digestion procedure. Gel pieces were also cut from
the same position in lanes 4, 6 and 8. LC-MS/MS was performed separately on
each sample and the sum identity of each individual peptide detected from all
lanes is presented. There were not any detectable levels of Ku-specific peptides
from lanes 4, 6 and 8. In both the number of different peptides and appearance
of individual peptides from lanes 3, 5 and 7 the majority mapped to the Cterminus of the Ku70 subunit (amino acids 545-605). These peptides were only
generated in the absence of a Ku-DNA complex suggesting a local
conformational change.
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peptide
1
2
3
4
5
6
7
8
9
10
11
12
13

mass
1573.82
1701.88
1651.85
692.38
1806.91
1311.64
2418.15
1506.78
1125.53
1691.85
936.55
1557.92
1172.69

Ku70 peptide
NIYVLQELDNPGAK
VHFEESSKLEDLLR
TFNTSTGGLLLPSDTK
YTPRR
MPFTEKIMATPEQVGK
HDNEGSGSKRPK
HDNEGSGSKRPKVEYSEEELK
RPKVEYSEEELK
VEYSEEELK
VEYSEEELKTHISK
AYGLKSGLK
SGLKKQELLEALTK
KQELLEALTK
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amino acids
101-114
231-244
302-317
400-404
446-461
545-556
545-565
554-565
557-565
557-570
587-595
592-605
596-605

IV. DISCUSSION AND CONCLUSIONS

Redox-dependent biochemical and structural changes in Ku:
Ionizing radiation induces a variety of DNA damage such as, double-strand
breaks, single-strand breaks and variety of DNA base oxidations within the cell.
IR and radiomimetic drugs can also increase the levels of reactive oxygen
species thereby having the potential to activate proteins in the non-homologous
end joining pathway. ROS has been measured in vivo in mice with solid tumors
compared to control mice upon radiation-induced DNA damage. Enzymes
involved in antioxidant functions were assessed and found to be increased in
mice with tumors, and this was attributed to more damage occurring in cancerous
cells with activation of complex signaling pathways (Agrawal, Choudhary et al.,
2001; Agrawal, Chandra, et al., 2001; Schmidt-Ullrich et al., 2000). Thus, there
are clear lines of evidence that IR can cause DNA DSBs and elevate reactive
oxygen species and this has some therapeutic efficacy against cancerous cells.
While we were not the first to suggest a link between some type of redox
regulation of the human Ku protein (Zhang and Yaneva, 1993), we have been the
first to report that Ku is undergoes a redox-dependent conformational change
and map that region on the protein. The presence of sulfhydryl (-SH) groups on
cysteine amino acids can lead to dynamic changes in the three-dimensional
structure based on the local environment of the protein. Cysteine amino acids on
proteins are known to be able to make disulfide bonds between their sulfhydryl
R-groups called cystine represented by this configuration CH2-S-S-CH2.
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Reduction of disulfides by DTT breaks the disulfide bond and makes the Rgroups take on this configuration CH2-SH HS-CH2. Oxidation by diamide or
performic acid reagent causes formation of cysteic acid residues which is
represented by CH2-SO3-

-

3

OS-CH2. These reagents for the oxidation and

reduction of disulfide bonds serve as useful tools to mimic the redox biochemistry
that can occur on proteins under oxidative stress. Ku contains 15 cysteine
residues throughout the heterodimer. Ku70 contains cysteines at positions 66,
150, 389, 398 and 585 while the Ku80 subunit contains cysteines at positions 13,
157, 235, 249, 296, 338, 346, 418, 493 and 638. Within specific globular
domains of Ku, Cys 585 is within the Ku70 C-terminal domain and Cys 638 is in
the Ku80 CTD. Mutation of a variety of these cysteines is currently an active
area of research in our lab. Hopefully, the identity of the specific cysteine(s)
responsible for redox can be identified and then the effect of making a mutation
at a particular site could be observed in the cell. Thus, there are multiple centers
in Ku where redox chemistry can occur.
Mechanistically, how could the redox change in Ku influence it’s DNA
binding activity at DSBs? The effect of oxidative stress on the NHEJ pathway
has been assessed and reduced repair capacity was found to be caused by
modulation of DNA-PK activity (Boldogh et al., 2003). It has also been observed
that in different phases of the cell cycle the reducing power varies and one could
envision Ku binding and DNA-PK activation being regulated by these cellular
conditions. This is also very logical because the NHEJ operates in all phases of
the cell cycle to repair DSBs and this would be dependent on the concentrations
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of proteins that might carry out the reduction of Ku and DNA-PK. Our data
demonstrate that koff rates for Ku under oxidizing conditions is significantly
greater than that observed under reducing conditions and this is the primary
effector for the change in DNA binding as assessed in EMSA and anisotropy
assays. Thus, in a reducing environment, Ku will stay bound to the DNA end
longer increasing the likelihood for DNA-PKcs to bind and form the DNA-PK
complex, ultimately initiating the NHEJ pathway. How this event might occur
biologically in vivo in the cell will be explained later. Structural alterations in the
Ku heterodimer upon binding DNA are known to be a prerequisite for DNA-PK
activation (Singleton et al., 1999; Gell and Jackson, 1999). A change in the
redox-status of Ku conditions represents one possible mechanism to regulate
this conformational change. This leads to one possible model where changes in
DNA-PK activity is altered as a function of ROS (Boldogh et al., 2003) and
consequently a reduction in Ku-DNA complex formation is observed at DNA
because Ku is oxidized and exiting the DNA termini more rapidly. A drug agent
that could possibly act to reduce Ku could result in a more stable complex
formation where Ku dissociates less rapidly. This would promote more favorable
NHEJ reactions and a better ligation efficiency by the DNA ligase IV/XRCC4/XLF
complex.
The redox-depedent conformational change in Ku is supported by multiple
lines of experimental evidence. While there are specific regions of Ku that are
hypersensitive to redox status, the overall conformation of Ku is more accessible
under the oxidized conditions. This was apparent in the limited proteolysis
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experiments demonstrated by SDS-PAGE and MALDI-TOF mass spectrometry
analysis demonstrating greater trypsin accessibility to a variety of regions under
the oxidized conditions in Figures 12 and 13. It would be counterintuitive to
anticipate that a change in redox would dramatically remodel the structure of the
Ku70 and Ku80 subunits due to their overall structural similarity minus the Cterminal domains. The reasoning behind this line of thought is reflected by both
the same series of bands appearing in both oxidized and reduced lanes in Figure
12, and overlapping peptides being cut under both redox conditions in Figure 13.
Also, a more open conformation is consistent with the different r-max values
observed for Ku bound to DNA under the different redox conditions. Anisotropy,
a measure of how molecules tumble in space, is likely to be effected by Ku being
in multiple conformational states. The more open configuration of Ku in the
oxidized state is also consistent with more rapid dissociation from the DNA and
patterns in proteolysis experiments. If the Ku ring adopts a more flexible,
conformation, the likelihood of movement along a duplex would be greater, and
thus on a DNA substrate where movement results in dissociation, the rate would
be expected to be greater.
Our results from limited proteolysis and mass spectrometry analysis are
supported by the Ku crystal structure. The peptide region of amino acids 300325 which contain the tryptic cut sites are positioned on the left pillar region
where the bridge meets at the DNA binding site of Ku. Residues 301-324 where
redox-dependent changes occurred in Ku during limited proteolysis are colored
green in Figure 14. Lys299 and Arg301 are pointed with their R-groups outward
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and are very highly accessible to trypsin digestion in the bridge region. Also,
Arg325 which represents the secondary cut site from the tandem mass
spectrometry data in Table 2, and also has its R-group deflected outward making
it highly accessible to digestion by trypsin. This amino acid is also in a loop
between the βL and βM anti-parallel β sheets with good solvent accessibility.
The flexibility of these two β sheets are anchored by structure donated from the
Ku80 subunit. The two DTT-protected amino acids, Lys317 and Arg318 depicted
in blue, lie within the βL sheet and are less accessible to trypsin digestion as
shown in Figure 13. Interestingly, a nearby cysteine amino acid, Cys493 shown
in blue, was detected nearby to the proposed site of redox-dependent
conformational change on the Ku80 subunit. Also, within close spatial proximity
to our site of conformational change is a tryptophan residue, W276, colored in
magenta. We propose in this model that this is the amino acid that is responsible
for the fluorescent quenching seen in the pre-steady state kinetic analysis using
the stopped-flow technique (Andrews et al., 2006). Preliminary data indicated
that the intrinsic fluorescence of Ku had an excitation maximum at 280 nm and
broader emission at 350 nm indicative of tryptophan fluorescence. Our modified
crystal structure model of Ku supports a redox-dependent change in local
structure around amino acids 300-325 in the Ku70 subunit. Some type of
disulfide interaction could possibly be modulated by Cys493 since it is also in
close proximity to the redox-sensitive region of Ku that further support our model.
Therefore, we have modeled a novel redox-sensitive site on Ku on the existing
crystal structure from differential peptide cleavage data from limited proteolysis
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and mass spectrometry. Thus, we can conclude that changes in the distribution
of peptides from limited proteolysis between the oxidized and reduced forms of
Ku gives us direct evidence for a structural change in this protein.
Since we could not detect quenching of Ku upon binding DNA under
oxidized conditions, we hypothesize this result is consistent with a more open,
flexible conformation. In our structural model in Figure 14, the Trp might not be
locked into a strict conformation, so the degree of quenching may be reduced
upon DNA binding. Most interesting is the alteration in the binding mode, twostep versus one-step, observed under partially and fully reduced conditions,
respectively (Andrews et al., 2006). A two step model for binding observed
under partially reduced conditions required a step before or after the initial
interaction with DNA. Ku might exist in equilibrium between two states, only one
of which will bind DNA and exhibit quenching, then the additional step could be
modeled as a slow change in conformation to the active DNA binding
conformation. The possibility of redox regulation of Ku is interesting because
there are not any disulfide bonds present in the crystal structure of free Ku or the
DNA-bound Ku (Walker et al., 2001). Furthermore, there are no coordinated
metals present which could also serve as redox centers. The positioning of
Cys493 in Ku80 (Figure 14) is potentially interesting in that redox dependent
alterations in this region could help explain the altered accessibility of Lys317
and Arg318. However, preliminary data from mutation of this cysteine, suggest
that it is not involved in redox regulation of Ku-DNA binding. This region also
provides important contacts with DNA. Importantly, one of these contacts
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involves Trp276 which is one of the few Trp residues within the DNA binding
region and is known to contact the DNA phosphate backbone (Walker et al.,
2001). Trp276 might be the residue that is quenched upon binding DNA. A
redox dependent alteration in this region could then account for the inability to
detect fluorescence quenching under oxidized conditions. The reactivity of Cys
residues is also a function of local electrostatic environment in which the residue
resides (Nelson and Creighton 1994; Kortemme and Creighton, 1995). From
data we have obtained, we have hypothesized one or more cysteine residues
and likely a tryptophan residue are involved in a redox-modulated DNA
dependent mechanism for Ku binding.
A few different mechanisms could take place in vivo to modulate the redoxdependent change that we have observed in the Ku protein. One mechanism
involves DNA-mediated charge transport (CT), which could have the potential to
affect the conformational change in redox-sensitive proteins like Ku. DNAmediated CT has been recently touted as a mechanism by which p53, and DNA
repair proteins containing Fe-S clusters sense DNA damage through increases in
ROS and undergo redox-sensitive conformational changes (Merino et al., 2008).
Other DNA repair proteins such as glycosylases are anticipated to use this
mechanism to scan and sense DNA damage to mediate repair. How does DNACT actually work? In one set of experiments, the authors have a duplex DNA
sequence that contains the p53 concensus binding sequence and an
anthraquinone group, which serves as the photooxidant upon excitation at the
correct wavelength for the photoreactive group (Augustyn et al., 2007). After
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excitation the anthraquinone group injects an electron hole that travels through
the duplex DNA and causes oxidation in bound p53. This leads to an oxidation in
p53, which is known to cause a conformational change and disrupt its binding to
DNA. The point of these experiments is that the photooxidation of the
anthraquinone group is supposed to mimic free radicals that can arise from DNA
damage-induced reactive oxygen species. This unstable electron species can
then alter a protein’s oxidation state and cause oxidation of disulfide bonds
thereby changing the conformational state of the protein and hence its DNAbinding ability.
Another mechanism that could serve to change the redox status of Ku,
could be redox factor proteins that directly interact with Ku to alter this protein’s
DNA end binding capability. This phenomenon would logically other DNA repair
proteins that have oxidizing or reducing potential in the nucleus. Specific
members of the mammalian base excision repair (BER) pathway have been
implicated in binding to specific proteins in relation to transcription of genes. This
frequently involves a redox-sensitive component in the BER pathway.
Ape1/ref1(Apurinic/apyrimidinic endonuclease/redox effector factor) is a primary
component of BER and the major mammalian AP endonuclease. Upon oxidative
DNA base damage apurinic/apyrimidinic sites are created within the DNA duplex
and a 5΄ nick in the phosphodiester backbone of DNA is made by Ape1/ref1,
which leaves a 3΄-hydroxyl and a 5΄-deoxyribose phosphate that flanks the
nucleotide gap. The redox portion of Ape1/ref1 resides in the more N-terminal
part of the protein after the nuclear localization sequence, while DNA repair
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activity overlaps with residues important for the former and continues through the
C-terminus. Ape1/ref1 is known to control a variety of transcription factors in a
redox-sensitive manner and is actually post-translationally modified itself by a
critical regulator of cellular ROS, thioredoxin, a dithiol-reducing enzyme, such
that Ape1/ref1 is reduced at critical cysteine residues (Evans et al., 2000).
Ape1/ref1 has been demonstrated to interact with a variety of transcription
factors and stimulate their DNA binding. Ape1/ref1 was found to facilitate binding
of the transcription factors Fos and Jun to DNA, which form the AP-1 complex in
a redox-dependent manner by reduction of cysteines on each molecule
(Xanthoudakis et al., 1992). Also, the tumor suppressor protein, p53 is known to
form a disulfide bond between cysteine residues under oxidized conditions. A
redox-dependent activation occurs by Ape1/ref1 to reduce the disulfide bridge,
which allows for p53 binding to DNA and act as a transcription factor for multiple
genes (Ueno et al., 1999). Thus, Ape1/ref1 is capable of reducing cysteine
amino acids on proteins that act in transcription and DNA damage signaling
events in the cell.
There are possible connections that suggest Ape1/ref1 and Ku could
interact which might explain how the redox-dependent DNA binding and
structural changes could occur in the cell. One such, potential interaction was
established years ago bewteen Ape1/ref1 and Ku describing them as
transcriptional coactivators. An N-terminal interaction of Ape1/ref1 bound to Ku
was found to function as a negative-calcium response element binding protein
(Chung, 1996). Another report has described a similar binding event with Ku and

143

ref1 as part of the hemin response element binding protein (HREBP) (Reddy et
al., 1998). Ku was found only to bind to microcircular DNA that contained the
hemin response element in the presence of ref1 and another unidentified protein.
More recently, a new member of the mammalian AP endonuclease family has
been discovered based on a similarity to phosphopeptide binding forkheadassociation (FHA) domains to polynucleotide kinase and aprataxin and termed
PALF (PNK and APTX-like FHA protein) (Kanno et al., 2007). This protein
contains a unique zinc-finger motif termed a CYR (cysteine-tyrosine-arginine),
possesses 3΄-5΄ endonuclease as well as AP endonuclease activities, and is
apparently capable participating in SSB and DSB responses. The most
interesting aspect of this study was that multiple NHEJ proteins were identified
from running HeLa cell extracts over a His-tagged PALF affinity column and
identifying interacting proteins by tandem mass spectrometry. The NHEJ
proteins DNA-PKcs, Ku80, Ku70 as well as BER proteins poly-ADP ribose
polymerase 1(PARP1), ligase IIIα and XRCC1 were found to bind to the column.
Furthermore, glutathione S-transferase (GST) tagged Ku80 and DNA ligase IV
were shown to directly interact with PALF, and phosphorylated XRCC4 was able
to interact with the FHA domain of PALF (Kanno et al., 2007). This is very
exciting evidence for a connection between the BER and NHEJ pathways since
this protein physically interacts with both groups and also interacts with not only
Ku, but multiple NHEJ protein members. Thus, data demonstrates the two most
likely candidates to modify Ku in a redox-sensitive manner are Ape1/ref1 and a
related family member, PALF and begs for further studies.
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A connection between the base excision repair pathway and NHEJ is both
very exciting and logical considering that reactive oxygen species can be
involved in activating both pathways. We have devised a model of how redoxdependent conformational changes occur in the human Ku heterodimer (shown
in Figure 32) based on experimental data from our paper (Andrews et al., 2006)
and likely candidate mechanisms and/or proteins that may be the source of this
modification. Once again, Ape1/ref1 complex is an integral part of the base
excision repair pathway which removes single damage or oxidized bases that
occur from oxidative stress and has been shown to interact with Ku. A new
relative to Ape1, PALF, shown to interact with various proteins of NHEJ increase
the likelihood that these endonucleases are involved in regulation of Ku and
response to DNA double strand breaks. Furthermore, a generalized mechanism
of the DNA getting activated by free radicals and carrying electrons that change
DNA repair proteins by redox is evoked in the DNA-mediated charge transport
mechanism.
DNA-dependent conformational changes in Ku:
As discussed earlier, Ku is a critical component of the NHEJ and V(D)J
recombination pathways and possesses an open channel structure which
facilitates its role in DNA binding. Since there are no apparent differences in the
two crystal structures between free Ku and DNA–bound Ku, the dynamic nature
of DNA binding suggests the potential for Ku conformational changes to
accompany DNA binding. Since 2001 there have not been any significant
advances in studying how binding of duplex DNA molecules affect the full-length
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Ku heterodimer. As mentioned in the last section of the Discussion, work from
our lab has demonstrated a reversible redox-dependent change in Ku structure
that accompanied an alteration in DNA binding (Andrews et al., 2006). From
these set of experiments, we were able to map discrete redox-sensitive tryptic
sites to the bridge and pillar region on Ku70 suggesting a conformational change
of Ku under reduced conditions. Our study extended earlier analysis of the redox
effect on Ku where sulfhydryl groups were known to be modulated (Zhang and
Yaneva, 1993). However, in order to simplify our limited proteolysis analysis of
Ku under redox we did not add duplex DNA to the reactions.
Ku structure has also been assessed as a function of IP6 binding where
decreased protease digestion was observed in the presence of IP6 (Hanakahi
and West, 2002). The authors hypothesized this was a result of a structural
difference between the two forms of Ku, although other factors affecting the
conformation may have not been taken into account, such as pH of the reaction
conditions. This same report assessed protease digestion in the presence and
absence of DNA, with Ku bound to DNA resulting in reduced protease cleavage.
However, the authors used sheared calf thymus DNA as a substrate for Ku which
has the potential of generating a heterogenous population of Ku-DNA complexes
and makes interpretation of the purported structural change considerably more
difficult. Furthermore, this alteration in protease sensitivity was not mapped to
either the Ku70 or Ku80 subunit. The results determined drastic changes in the
proteolytic cleavage of IP6-bound versus free Ku structure. These results are a
bit surprising because a small molecule like IP6 should not cause such a drastic

146

change in observable protein structure. We would predict that the change would
be more subtle in the proteolytic pattern like we have observed with Ku in the
presence of DTT in Figure 12. Preliminary data from our lab could not detect a
difference with Ku and IP6 mixing experiments in the context of using limited
proteolysis and SDS-PAGE to look for drastic structural changes that were
observed by the aforementioned authors.
While the three-dimensional crystal structure gives us a well-defined model
of how the Ku-DNA interaction occurs, a significant portion of both Ku70 and
Ku80 were not present in both the free and DNA-bound Ku crystal structures.
The limitation of X-ray crystallography is only one representative version is
observed of what are likely to be dynamic complexes that in the cell interact with
substrates and binding partners. Cryo-electron microscopy analysis of Ku-DNA
complexes has given us some indication that DNA-dependent conformational
changes in Ku structure do indeed occur with binding to duplex DNA (RiveraCalzada et al., 2007). In order to examine Ku conformational changes as a
function of DNA binding, we employed high resolution chemical modification
coupled with mass spectrometry to completely analyze Ku-DNA complexes on
specific defined substrates.
In our recent paper, we utilized chemical modification of lysines combined
with mass spectrometry to determine specific amino acids in Ku that display
differential reactivity upon DNA binding (Lehman et al., 2008). Once again,
differences in the biotinylation pattern can be attributed to an altered structure of
the protein or accessibility of the region to the modification reagent as depicted in
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the flow-chart model for our procedure in Figure 6. This methodology has
recently been established and has identified multiple novel protein-nucleic acid
contacts on a variety of other proteins including the HIV proteins: reverse
transcriptase, Gag and integrase and the DNA repair protein, replication protein
A (Kvaratskhelia et al., 2002; Datta et al., 2007; Shell et al., 2005; Deval et al.,
2008).
Predictions of classes of biotin modifications would fall into one of three
categories: biotinylations that occur on a lysine residue in the presence of Ku
and Ku-DNA complexes, biotinylations that occur on a lysine only in the free Ku
form that get blocked with DNA, biotinylations which take place only when DNA is
present in the reaction. These could be further divided into two subtypes: A
biotinylation that takes place near the predicted DNA binding domain and bridgepillar region or a chemical modification that occurs at site where nucleic acid are
not predicted or known to contact Ku. Our observations found all three types of
modifications and subtypes at all concentrations of NHS-biotin used. The
abundance of biotinylation events were indiscriminate and took place at a
particular site with free and DNA-bound Ku. Very few events took place where a
biotinylation site was blocked when DNA was present in the reaction and are
shown in Table 3 and throughout Appendix 1.
Our analysis revealed one such site, K331 on Ku that was not modified in
the presence of DNA, and this amino acid lies within α-helice 9 (inbetween βsheets M and N) in the pillar region. The decrease in reactivity is attributed to a
DNA steric block, such that K331, while not making direct DNA contact in the

148

crystal structure has reduced accessibility. In addition, K265 of Ku80 was also
not modified in the presence of DNA, which is a change that is reflected by a
steric hindrance from the DNA. We were also able to identify changes in the
biotinylation status of specific lysine residues on peptides which represent the
Ku70 C-terminal SAP domain, which is thought to contact DNA directly, yet never
concretely confirmed in Ku. This series of biotinylations were only observed in
the absence of DNA in the C-terminus of the Ku70 subunit. Biotinylations on
peptides represented by residues K539 and K582 were consistent on two
different DNA substrates and in multiple experiments. Therefore, these
differential biotinylation events were interpreted as changes in the scaffolding
architecture of the Ku70 C-terminal SAP domain, such that a conformational
change must have taken place.
Other data that we observed supports the hypothesis that a DNA-dependent
rearrangement occurs in the SAP-domain. A 10 kDa proteolytic fragment
mapped to Ku70, residues 545-605 in reactions with Ku where DNA was not
present. This event showed that DNA-induced steric hindrance in the Ku70 CTD
possessed some altered protease accessibility. Residues 533-609 are not
present in the Ku70 DNA-bound crystal structure. Additionally, residues 538-559
are not observed in the non-DNA bound structure, both of which are contained
within this region. Interestingly, the 10 kDa proteolytic fragment mapped to
amino acids 545-605, which represents a fair portion of the DNA-binding SAP
domain of Ku70. Amino acids 538-559 absent from the crystal structure extend
and terminate into a structure comprising 3 α-helices in the non-DNA bound Ku
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structure within amino acids 560-609. This stretch of amino acids likely
represents a movable hinge that twists into the major or minor groove of DNA
and gets partially blocked from trypsin digestion in the DNA-bound form. This
observation is supported by the experiments with limited proteolysis and Western
blotting with antibodies against the Ku70 C-terminal region. Proteolysis occurs
with generation of a 37 kDa peptide precursor labeled with one asterisk in Figure
30 with the next cut generating the 25 kDa band marked by two asterisks. The
antibody (N3H10) used to probe this Western blot recognizes amino acids 506541 of Ku70. The C-19 antibody recognizes the extreme C-terminal end within
the final 30 amino acids of Ku70 (Figure 3 and 25) and was used to probe the
blots in Figures 29 and 30. Sequences identified within the 10 kDa peptide did
not include amino acids 506-541, but followed that stretch of peptides. This is
eveidence why both Ku70 antibodies recognize the 37 kDa peptide cleavage
product marked with one asterisk in Figures 29 and 30, yet only the C-19
antibody detects the 10 kDa peptide. However, the tryptic digestion pattern and
biotin modification patterns indicate changes in the flexible linker region of Ku70
in amino acids N-terminal to the SAP domain and directly within the SAP domain
itself. Therefore, a direct interface between the SAP domain and DNA must
exist. The combination of chemical modification and limited protelysis data
suggest that the C-terminal Ku70 SAP domain undergoes a change in secondary
structure, and scaffolding within the DNA occurs.
Since the integrity and dependence of the Ku80 C-terminal domain in
binding DNA-PKcs can not be underscored and a high probability exists that
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binding of Ku to DNA induces a structural change in this region, we sought to
examine this possibility using the NHS-biotin modification system. Biotinylation
differences could not be detected between the free and DNA-bound form of Ku in
the Ku80 CTD shown in Table 3. This result was not astonishing because of the
high solvent accessibility of the Ku80 CTD. Independent solution structures of
the C-terminal region of Ku80 have modeled six α-helices binding with an
extreme C-terminal unstructured loop dispensable for DNA-PKcs binding, while
the α-2 and α-4 helices have been described to be very hydrophobic and may
represent binding pockets for protein-protein interactions (Zhang and Zhu et al.,
2001).
The flexible linker region of the Ku80 CTD and residues directly N-terminal
of this are probably the portion responsible for structural changes in this domain.
Consistent with this possibility was the demonstration that using limited
proteolysis with site-specific antibodies we were able to detect conformational
changes in this region of the Ku80 subunit. This notion is supported by the
observation of the doublet above the 19 kDa Ku80 CTD band when DNA is not
present shown Figure 26. This Ku80 DNA-dependent conformational change
could cause this region to be more capable of accommodating the binding of
DNA-PKcs for a stable interaction. The Ku80 CTD is necessary for in vitro and in
vivo activation of DNA-PKcs (Singleton et al., 1999). A direct interaction between
Ku80 CTD and DNA-PKcs is known to take place and removal of this region
resulted in radiation sensitivity and impaired V(D)J recombination events (Gell
and Jackson, 1999; Singleton et al., 1999). Our comprehensive biochemical
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examination of Ku support and extend previous single molecule structural EM
analysis suggesting that the C-terminal domain of Ku80 undergoes some type of
conformational change upon binding DNA ends.
There are multiple biological consequences of DNA-dependent steric
hindrance changes observed in the C-terminal domains of the Ku70 and Ku80
subunits. The obvious implication for the Ku80 CTD is for the DNA-dependent
activation of DNA-PKcs to accommodate the binding of the large subunit. The
importance of the Ku80 C-terminus in DNA-PK activation, leads to the question
of how this interaction is influenced by DNA binding and remains an open
question. One can envision a change in scaffolding of Ku70 and Ku80 CTDs
upon DNA binding, thereby rendering these domains more accessible for docking
the large 469 kDa DNA-PKcs component. This and other possibilities are
modeled in Figure 33. In addition, disruption of this interaction may regulate
phosphokinase activities including facilitating binding of other NHEJ components
and release of Ku and DNA-PKcs from the termini prior to ligation. Clearly,
additional analysis of the role of DNA-dependent conformational changes and
determination of the sites of DNA-protein contacts within DNA-PK are necessary
to determine how DNA-PK is activated. Recently the conserved α5 on Ku has
been proposed to have an opposing role in telomere silencing on the Ku80 face
and NHEJ on the Ku70 face in a yeast model system (Ribes-Zamora et al.,
2007). This likely involves some type of conformational change mechanism to
accommodate these very different cellular functions. One very likely function of
DNA-dependent conformational changes in Ku80 has been recently hinted at in a
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study with Ku, DNA ligase IV and XRCC4. Amino acid residues 644-748 of DNA
ligase IV contain a BRCT domain, which are widely known to facilitate proteinprotein interactions. The authuors found that the Ku80 CTD was not required but
enhanced the binding of the two NHEJ proteins (Costantini et al., 2007). This
event has been incorporated into our model in Figure 33 as a possible reason
why DNA-dependent conformational changes occur in this region.
This dissertation thesis work has made significant advances in
understanding the biochemistry and structural regulation of the Ku heterodimer,
an essential component of the human non-homologous end joining pathway. Ku
is necessary for the initial recognition of free DNA ends that occur from double
strand breaks. In this body of work, we have identified a redox-sensitive
component which represents a novel mode of regulation of Ku in vitro. Redox
was clearly demonstrated to affect the native structure of Ku and alter its ability to
remain bound to duplex DNA. This has a direct implication for cellular redox
caused by DNA damage and reactive oxygen species that ensue from this
process. We also determined that Ku was capable of undergoing a DNAdependent conformational change in both of its C-terminal domains. This could
represent a necessary and overlooked biochemical step that is not necessarily
observed in conventional assays that measure NHEJ both in vitro and certainly in
vivo. By understanding both the redox and DNA-dependent conformational
changes that manifest in Ku, we can discern the individual steps of DNA-PK
activation and NHEJ. Furthermore, intimately knowing the important
contributions of Ku structure could serve as step to think about rational screening
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for small molecule inhibitors. Inhibiting Ku and or DNA-PK would have a logical
implication for cancer chemotherapy as we have previously demonstrated that IR
and cisplatin have a synergistic effect on killing cancer cells and this directly
involves the NHEJ pathway.

154

Figure 32. Model of redox-dependent conformational changes in Ku. The
following model has the Ku70 subunit depicted in light blue and the Ku80 subunit
in dark blue with individual CTDs for Ku70 in yellow and Ku80 in green. We
hypothesize that two forms of Ku exist in the cell, oxidized and reduced and are
regulated by reactive oxygen species in the cell. Oxidized Ku is more open and
slides off DNA more rapidly compared to the reduced tighter conformation Ku
shown at the top of the model. A novel reduction of Ku upon DNA damage is
proposed to be contributed from three molecules including two base excision
repair proteins: PNK and APTX-like FHA protein (PALF) and the
apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (Ape1/ref1) and
glutathione.
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Figure 33. Model of DNA-dependent conformational changes in Ku. The
following model has the Ku70 subunit depicted in light blue and the Ku80 subunit
in dark blue with individual CTDs for Ku70 in yellow and Ku80 in green. Arrows
from Ku structures point to either a non-DNA bound form of Ku that was treated
with trypsin protease and led to a large number of peptides, or a DNA-bound
form of Ku that was more protected from tryptic cleavage. The theoretical
consequences of Ku-DNA complex formation are directed with arrows.
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Appendix 1
Figure a. Tandem mass spectrometry analysis of biotinylated peptides. A.
shows the elution profile times for peptides from 0-115 min with their relative
abundance. Peptide 1 from Ku70 in Table 3, TFNTSTGGLLLPSDTKR, was
found to have an elution profile time at 77.74 min. B. This peptide underwent
collisionally induced dissociation (CID) to produce the series of b and y ions
depicted with their individual m/z ratios. CID spectra identified K317 as the
residue that underwent chemical modification with NHS-biotin.
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Figure b. Tandem mass spectrometry analysis of biotinylated peptides. A.
shows the elution profile times for peptides from 0-115 min with their relative
abundance. Peptide 2 from Ku70 in Table 3, QIILEKEETEELKR, was found to
have an elution profile time at 71.55 min. B. This peptide underwent collisionally
induced dissociation (CID) to produce the series of b and y ions depicted with
their individual m/z ratios. CID spectra identified K331 as the residue that
underwent chemical modification with NHS-biotin.
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Figure c. Tandem mass spectrometry analysis of biotinylated peptides. A.
shows the elution profile times for peptides from 0-115 min with their relative
abundance. Peptide 3 from Table 3, ELVYPPDYNPEGKVTK, was found to have
an elution profile time at 21.60 min. B. This peptide underwent collisionally
induced dissociation (CID) to produce the series of b and y ions depicted with
their individual m/z ratios. CID spectra identified K539 as the residue that
underwent chemical modification with NHS-biotin.
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Figure d. Tandem mass spectrometry analysis of biotinylated peptides. A.
shows the elution profile times for peptides from 0-115 min with their relative
abundance. Peptide 4 from Ku70 in Table 3, FTVPMLKEACR, was found to
have an elution profile time at 80.16 min. B. This peptide underwent collisionally
induced dissociation (CID) to produce the series of b and y ions depicted with
their individual m/z ratios. CID spectra identified K582 as the residue that
underwent chemical modification with NHS-biotin.
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Figure e. Tandem mass spectrometry analysis of biotinylated peptides. A.
shows the elution profile times for peptides from 0-115 min with their relative
abundance. Peptide 5 from Ku80 in Table 3, IAAYKSILQER, was found to have
an elution profile time at 77.45 min. B. This peptide underwent collisionally
induced dissociation (CID) to produce the series of b and y ions depicted with
their individual m/z ratios. CID spectra identified K582 as the residue that
underwent chemical modification with NHS-biotin.
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Figure f. Tandem mass spectrometry analysis of biotinylated peptides. A.
shows the elution profile times for peptides from 0-115 min with their relative
abundance. Peptide 6 from Ku80 in Table 3, IKTLFPLIEAK, was found to have
an elution profile time at 81.53 min. B. This peptide underwent collisionally
induced dissociation (CID) to produce the series of b and y ions depicted with
their individual m/z ratios. CID spectra identified K534 as the residue that
underwent chemical modification with NHS-biotin
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Figure g. Tandem mass spectrometry analysis of biotinylated peptides. A.
shows the elution profile times for peptides from 0-115 min with their relative
abundance. Peptide 6 from Ku80 in Table 3, TLFPLIEAKK was found to have an
elution profile time at 83.11 min. B. This peptide underwent collisionally induced
dissociation (CID) to produce the series of b and y ions depicted with their
individual m/z ratios. CID spectra identified K543 as the residue that underwent
chemical modification with NHS-biotin

171

172

Figure h. Tandem mass spectrometry analysis of biotinylated peptides. A.
shows the elution profile times for peptides from 0-115 min with their relative
abundance. Peptide 7 from Ku80 in Table 3, FNNFLKALQEK, was found to
have an elution profile time at 83.11 min. B. This peptide underwent collisionally
induced dissociation (CID) to produce the series of b and y ions depicted with
their individual m/z ratios. CID spectra identified K660 as the residue that
underwent chemical modification with NHS-biotin
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Figure i. Tandem mass spectrometry analysis of biotinylated peptides. A.
shows the elution profile times for peptides from 0-115 min with their relative
abundance. Peptide 8 from Ku80 in Table 3, KFLAPK, was found to have an
elution profile time at 67.69 min. B. This peptide underwent collisionally induced
dissociation (CID) to produce the series of b and y ions depicted with their
individual m/z ratios. CID spectra identified K703 as the residue that underwent
chemical modification with NHS-biotin
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